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Abstracts 
Metallothioneins are a family of low molecular weight, metal-binding proteins with an 
unusually high cysteine content. The metallothionein I/II isoforms (hereafter referred to 
as MT) have been demonstrated extensively in a number of studies to promote axonal 
outgrowth of a variety of central nervous system (CNS) neurons, both in vivo and in 
vitro, after traumatic injury. However, the precise mechanisms through which MT 
interacts with injured neurons to promote their regeneration after injury remains largely 
unknown. The goal of this thesis is to identify some of these molecular mechanisms in 
both the injured CNS and peripheral nervous system (PNS). 
The first part of this thesis aimed to identify how exogenous MT interacts with glia and 
neurons in the CNS after traumatic injury using the in vivo focal needle-stick injury 
model.  It was found that injection of fluorescently labeled-MT (488-MT) into the injury 
site led to a decrease in overall injury size compared to vehicle treatment (fluorescent-
unincorporated dye, AlexaFluor-488). Histological analysis found that 488-MT was 
present in both neurons as well as reactive microglia surrounding the injury site. The 
internalization of 488-MT by cortical neurons suggests that the injected 488-MT might 
interact directly upon injured neurons to promote regenerative axonal sprouting, which 
would be in accordance with prior studies demonstrating that neuronal internalization is 
required for MT to promote initial neurite outgrowth and elongation. 
To identify the signaling pathway through which MT exerts its effect upon neurons, the 
MT were co-injected with receptor-associated protein (RAP), an antagonist for megalin 
(a recently identified receptor for MT) into the injured cortex using the same injury 
model. The results demonstrated that the addition of RAP has blocked the effect of MT in 
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promoting regenerative axonal sprouting after injury, thus confirming that MT acts 
through LRP receptors-dependent pathways to exert its regenerative effect upon injured 
cortical neurons.  
The uptake of MT by microglia led to a further investigation into the direct effect of MT 
on the microglial response after injury. In vivo data suggested that the injection of 488-
MT caused a morphological change in reactive microglia.  There was also enhanced 
physical association between reactive microglia and regeneratively spouting neurons. 
Using a series of neuron-microglia co-culture and media exchange experiments, it was 
found that MT could block the inhibitory effect of cytokine-activated microglia had upon 
neurite outgrowth of cultured cortical neurons. Hence this demonstrates that MT might 
potentially modulate the microglial response, which indirectly leads to improvement in 
regenerative axonal sprouting after injury. 
The second half of this thesis evaluated the potential role of MT in promoting nerve 
regeneration in the PNS. The rationale for this study relates to recent reports that another 
neuroprotective protein, transthyretin, can promote neurite outgrowth of dorsal root 
ganglion (DRG) neurons via interaction with the megalin receptor (also a putative 
receptor for MT). To investigate the effect of MT in promoting neurite regeneration in 
the DRG neurons, MT was applied to DRG neuron cultures, which led to an 
improvement in axonal sprouting after scratch injury. To investigate in further detail the 
mechanism of action of this effect, a compartmentized in vitro injury model was 
established, which allowed the precise and restricted application of MT to either the 
axonal processes or neuronal soma immediately after axonal scratch injury. The length of 
regenerative axonal sprouts was measured 24 hours after injury, and a 4-fold or 1.4-fold 
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increase in regeneration was observed when MT was administered to either the soma or 
axonal compartments respectively (fold change relative to vehicle-treated control). 
Interestingly, this correlated with the expression of megalin, which was restricted 
primarily to the neuronal soma, with very little megalin labeling observed in axons. 
Finally, MT was found to promote DRG neuron regeneration via LRP- and MAPK- 
(mitogen-activated protein kinase-)-dependent pathway.  
Overall, this thesis has provided new insight to the field in understanding some of the 
precise mechanisms through which MT promotes neural regeneration in both CNS and 
PNS. It demonstrated that MT may potentially act directly upon microglia to modulate 
the extracellular environment in response to brain injury, which may then facilitate 
neuronal sprouting after injury in the CNS. This thesis also demonstrates that MT 
promotes peripheral nerve regeneration after injury via a megalin and MAPK-dependent 
mechanism. 
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Chapter 1 Literature Review 
1.1 Neuronal Response After Injury 
Injury to the nervous system has a devastating and often long-lasting detrimental impact 
upon the physical capabilities of people. The nervous system consists of the central 
nervous system (CNS), which includes the brain and spinal cord; and the peripheral 
nervous system (PNS), encompassing all nerves and ganglia external to the brain and 
spinal cord. Damage to the CNS in adults generally recovers poorly, in contrast to that of 
the injured PNS. Understanding the differences in regenerative capacity between the CNS 
and PNS may identify new therapeutic strategies for improving recovery of the injured 
CNS.  Hence, this review will focus on the factors that contribute to the different in 
regenerative outcome of neurons after injury in the CNS and PNS.  
 
Neurons are structurally composed of three primary cellular compartments: the soma or 
cell body (containing the nucleus), axons (transmit information to other neurons via 
synapses that connect with other neurons), and dendrites (the receiving terminals which 
form synapses with the pre-synaptic axons). Notably, the majority of published studies in 
this field have been focused upon the axonal response to injury and factors that facilitate 
axonal regrowth and re-connection. Several major areas of focus have been upon 
improving the regenerative sprouting of injured axons as well as modulating the 
extracellular environment to be more permissive and supportive for regenerative axonal 
growth. Therefore, the following review will be mainly focused upon the current 
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knowledge of the axonal response to injury, as well as the factors that influence the 
differences in the regenerative capacity after injury between the central and peripheral 
neurons. 
 
1.2 Axonal Degeneration in Response to Injury  
After injury axons generally undergo a degenerative response which can be separated into 
two categories: events that occur at the proximal nerve stump, (the proximal section of 
the injured axon that remains connected to the cell body), and the distal nerve stump 
(comprising the distal part of the injured axon that has became disconnected from the cell 
body after injury). It should be noted that axonal regeneration has generally been best 
characterised in peripheral nerves, due to their high accessibility in vivo as well as their 
ability to form long axonal bundles in vitro. Therefore the following sections will mainly 
summarize the current knowledge in the field collected from studies using peripheral 
nerves, unless otherwise specified. 
 
1.2.1 Degenerative Response to Axotomy at the Proximal Nerve Stump  
After complete axotomy (either primary or secondary axotomy), an initial ‘die-back’ or 
retraction of the proximal axon occurs. Axonal retraction generally ceases when the 
retraction reaches the first node of Ranvier, with the cell bodies staying intact after the 
injury (reviewed by S. Y. Fu and T. Gordon, 1997). Following axonal retraction, swelling 
occurs within the proximal end of the injured axon adjacent to the lesion site. This 
swelling is comprised of the accumulation of cellular contents, such as cytoskeletal 
proteins, smooth endoplasmic reticulum, mitochondria, which is presumably caused by 
 3 
disruption in the normal transport of these contents along axons (reviewed by J. W. 
Fawcett and R. J. Keynes, 1990 S. Y. Fu and T. Gordon, 1997). This progresses to the 
degeneration of the axons, through a process known as Wallerian degeneration, which 
will be discussed further in the next section (S. Y. Fu and T. Gordon, 1997).  
 
However, traumatic injury in the CNS does not always lead to complete axotomy of 
axons.  Instead, a diffuse form of axonal injury commonly occurs. While axotomy is 
absent, this diffuse form of injury generally leads to the substantial blockage of axonal 
transport, resulting in the accumulation of cellular contents and axonal swelling described 
above (as reviewed by M. Coleman, 2005). It has been reported in studies utilising an in 
vitro stretch-injury model performed upon cultured cortical neurons, that the stretch 
injury led to a significant change in ion permeability in the injured area of the axon, 
leading to the influx of ions such as calcium (A. Iwata et al., 2004). The unregulated 
influx of ions such as calcium triggers a range of intracellular mechanisms that contribute 
to secondary cellular degeneration. This will be further discussed in the following 
sections.  
 
1.2.3 Degenerative Response of the Distal Nerve Stump Following Axotomy 
The distal nerve stump of axotomised axons undergoes Wallerian degeneration, which is 
a sequence of events that led to the degeneration of the proximal nerve segment that has 
became separated from the cell body after injury. (as reviewed in S. Y. Fu and T. Gordon, 
1997; B. Beirowski et al., 2005). Transgenic mice that express Yellow Fluorescent 
Protein (YFP) in subsets of neurons (and their axons) has allowed continual time-lapse 
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imaging of individual axons after injury in living animals. This study has demonstrated 
that immediately after either crush or complete transection injury to sciatic nerves, an 
initial latency period occurs during which time the majority of the axons are observed to 
remain intact for 36-44 hours after injury (B. Beirowski et al., 2005). This latency period 
was defined as the time during which injured axons were still able to conduct action 
potentials, and able to display limited ultrastructural changes as assessed by electron 
microscopy (B. Beirowski et al., 2005). The use of YFP-expressing transgenic mice has 
also allowed the monitoring of the spatiotemporal pattern of axonal degeneration that 
occurs after different types of injury. It has been reported hat both complete nerve 
transection and crush injury led to a wave-like pattern in the propagation of axonal 
fragmentation (B. Beirowski et al., 2005). These results suggest that the degenerative 
process is active and regulated by a precise series of intracellular processes, rather than a 
set of passive events associated with the discontinued supply of cellular proteins to the 
distal parts of axons (J. T. Finn et al., 2000; B. Beirowski et al., 2005).  
 
One of the major biochemical drivers of this degenerative process is the disruption of ion 
homeostasis (including Na+ and Ca2+ ions) in axons after injury (as reviewed in W. 
Young, 1992). It is thought that injury that is sufficient to cause permeabilisation of the 
cell membrane of axons leads to an influx in Na+ ions as well as the passive diffusion of 
Ca2+ ions into the axoplasm (A. Iwata et al., 2004 and reviewed by B. Beirowski et al., 
2005). Notably, the post-injury ion homeostasis is a complicated process, which involves 
a vast diversity of ion channels. Hence, it is difficult to conclude the involvement of 
particular ions. However, studies using tetrodotoxin, which blocks the activity of voltage-
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gated sodium channels have resulted in blocking the increase of intracellular calcium that 
normally occurs after experimental axotomy in cortical neuron cultures, thus 
demonstrating that sodium influx might be coupled together with calcium influx (A. 
Iwata et al., 2004). This influx of calcium then leads to the activation of intracellular 
calcium-dependent proteases known as calpains, which trigger the induction of axon 
degeneration after injury (A. Buki et al., 1999). This is supported by studies reporting that 
application of both calcium channel blockers and calpain antagonists considerably delay 
or prevent the degenerative response of dorsal root ganglion (DRG) explants after 
axotomy in vitro (E. B. George et al., 1995).   
 
1.3 Regenerative Axonal Sprouting After Injury 
Studies have demonstrated that axons have an intrinsic capability to sprout in response to 
injury, which has largely been considered as an active response mediated by fundamental 
changes in gene expression profile, i.e. from “transmitting mode” to “growth mode”. 
These changes involve downregulating the expression of neurotransmission related 
proteins, and upregulating the expression of growth associated proteins (such as the 
cytoskeletal proteins, actin and tubulin), which bear similarities to the gene expression 
profile observed during neuron development (as reviewed by S. Y. Fu and T. Gordon, 
1997). These changes ultimately led to the formation of axonal sprouts (emanating either 
from injured processes or from the cell body) from neurons that have survived the initial 
degenerative process. While more than one sprout might originate from each neuron, 
similar to what is observed during development, only one sprout that ultimately reaches 
and re-connects with a target cell would be maintained, while the others would be 
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withdrawn (as reviewed by S. Y. Fu and T. Gordon, 1997; D. Muir, 2010). Interestingly, 
the initiation of the axonal sprouting response after injury has been demonstrated to be 
independent of upregulation of cytoskeletal proteins in the cell body.  This is based upon 
the very quick timeframe in which regenerative sprouting is initiated, as well as the 
observation that regenerative sprouting can occur from injured axons that have been 
completely isolated from the cell body. Therefore, initial regenerative sprouting and 
outgrowth appear to be an innate property of injured axons, and appear to be induced by 
the axonal transport of tubulin and actin into the proximal stump (M. A. Bisby and W. 
Tetzlaff, 1992). Further illustrating the significant role of microtubules in axon sprouting, 
the use of the microtubule stabilizing agent Taxol has been shown to improve neurite 
sprouting following injury in vitro and in vivo (V. Sengottuvel et al., 2011). Moreover, in 
primary cell culture preparations used for in vitro studies using both CNS and PNS 
neurons have shown that after the tissue preparation, these neurons were readily sprout 
regenerative neurites after being isolated, therefore suggesting that neurons have an 
intrinsic ability to sprout following injury. This highlights the importance in 
understanding the factors that contribute to the poor regenerative outcomes observed in 
the CNS after injury in comparison to the PNS.  
 
Interestingly, a process known as pre-conditioning has been identified whereby a 
conditioning lesion to the peripheral axon of a DRG neuron (which has both a peripheral 
and central axon) one week prior injury to the central axon significantly improves nerve 
regeneration into the lesion site of the spinal cord. The conditioning lesion leads to an 
increase in the expression of regeneration-associated genes, hence improvement in the 
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overall regenerative response after the second injury to the central axons (S. Neumann 
and C. J. Woolf, 1999). Several studies have reported that pre-conditioning injuries 
modulate the intrinsic regenerative properties of neurons through the activation of the 
JAK/STAT (Janus kinase / Signal transducers and activators of transcription) pathway (J. 
Qiu et al., 2005). This further demonstrated that if neurons are able to upregulate the 
proper cell machinery, they have the potential to regenerate after injury.  
 
1.4 Environmental Factors that Influence Regenerative Sprouting in Central and 
Peripheral Neurons After Injury  
As discussed previously, both central and peripheral neurons have an innate capacity to 
extend regenerative sprouts after injury.  This suggested that the difference between the 
relative regenerative capacity of CNS and PNS is due to the different extracellular 
environments present within these systems. To illustrate this, the inhibitory elements 
present in the CNS will first be discussed, followed by review of the known regeneration-
promoting elements present in the PNS.  
 
1.4.1 Factors that Affect Axonal Sprouting in CNS - Reactive Astrogliosis and Glial Scar 
Formation  
The formation of the glial scar is one of the major inhibitory factors that hinder 
regenerative sprouting after CNS injury. The glial scar represents a cellular and molecular 
barrier that encapsulates the cavity surrounding the wound area after injury (M. T. Fitch 
et al., 1999). The CNS glial scar is primarily comprised of reactive astrocytes, which in 
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response to the injury migrate robustly to surround the injury site (M. T. Fitch et al., 
1999; A. R. Filous et al., 2010).  
 
In response to injury, the astrocytes along the injury site first become reactive, which is 
classified by the upregulation of the expression of intermediate filament glial fibrillary 
acid protein (GFAP), and undergo hypertrophy and proliferation (as reviewed by R. Biran 
et al., 1999; A. Araque et al., 2001). Proteoglycans are one of the major inhibitory 
substrates present in the glial scar (as reviewed by J. Silver and J. H. Miller, 2004). There 
are four major types of proteoglycans produced by astrocytes: heparan sulphate 
proteoglycan (HSPG), dermatan sulphate proteoglycan (DSPG), keratan sulphate 
proteoglycan (KSPG) and chondroitin sulphate proteoglycan (CSPG) (P. C. Johnson-
Green et al., 1991). The CSPGs are the most inhibitory to neurite extension of both adult 
and embryonic neurons (as reviewed in J. Silver and J. H. Miller, 2004). Furthermore, 
CSPGs also inhibit the effect of growth promoting molecules such as laminin in 
cerebellar granule neuron cultures (C. L. Dou and J. M. Levine, 1994).  
 
Given that CSPGs expressed by reactive astrocytes are highly inhibitory to regenerative 
neurite sprouting after injury, it is feasible that modulating the activation of reactive 
astrocytes might lead to improvement in regenerative axonal sprouting after injury. This 
has been shown to be successful in studies using the enzyme chondroitinase, which 
digests the sidechains of CSPGs rendering them inactive (J.M. Massey et al., 2006).  
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Notably however, recent studies have demonstrated that reactive astrocytes also have 
important protective roles after CNS injury. Hence, studies that utilize transgenic mice 
with a GFAP promotor-driven herpes simplex virus-thymidine kinase transgene have 
revealed the complexity of the reactive astrocyte and glial scar formation in response to 
CNS injury. This strain of transgenic mice allows the selective ablation of proliferating 
and GFAP-expressing astrocytes using ganciclovir (antiviral agent) treatment, hence 
allowing the selective ablation of cells that express thymidine kinase, which in this case 
are reactive astrocytes (T. G. Bush et al., 1999; J. R. Faulkner et al., 2004; D. J. Myer et 
al., 2006). In these studies, brain injuries, including stab injury (T. G. Bush et al., 1999) 
or moderate controlled cortical impact (CCI) injury (D. J. Myer et al., 2006), were 
performed on both transgenic and non-transgenic wildtype mice treated post-injury with 
gancyclovir, to determine the effect of ablation of reactive astrocytes in these brain injury 
models. These studies have found that selective ablation of reactive astrocytes in injured 
transgenic mice results in an increase infiltration of leukocytes into the lesion area, 
together with greater numbers of inflammatory microglia/macrophages, (hence increased 
inflammatory response). Rather surprisingly however, the ablation of reactive astrocytes 
led to an exacerbation of neuronal loss in the injury site and loss of cortical volume (D. J. 
Myer et al., 2006;T. G. Bush et al., 1999). This suggests that reactive astrocytes might 
also have important protective roles in the injured CNS.  
 
The same transgenic mice have also been used to study the role of reactive astrocytes in 
either stab or crush injury models, representing either mild or moderate spinal cord 
injuries respectively (J. R. Faulkner et al., 2004). Similar to previous injury models the 
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targeted ablation of reactive astrocytes in both the stab and crush injured spinal cord led 
to increased inflammation and increased infiltration of inflammatory cells (especially 
macrophages) into the injury site. The depletion of astrocytes also led to the exacerbation 
of neuronal loss and neural degeneration, as well as the failure in repairing the blood 
brain barrier. Moreover, both of these injuries have diminished motor recovery in the 
absence of reactive astrocytes (J. R. Faulkner et al., 2004). Overall, these studies have 
demonstrated that the presence of reactive astrocytes is necessary for protection of 
neurons, as well as recovery from the injury. 
 
The injury environment is dynamic in which the cellular and molecular response of both 
astrocytes and neurons undergo rapid changes over time. This could explain the 
conflicting results shown by studies demonstrating that reactive astrocytes can be both 
protective and detrimental to neurons. The process of reactive astrogliosis and the 
formation of a glial scar are a rapid response to CNS injury that contained the injury site, 
and may subsequently prevent further spreading of damage from the injury. However, at 
later stages in the post-injury process when recovery and regeneration are important, a 
permissive cellular and molecular environment is required. Hence, the inhibitory factors 
should be cleared to allow a more supportive environment for axonal growth. This has 
been demonstrated in studies using chondroitinase ABC (ChABC), a bacterial enzyme 
that digests the glycosaminoglycan side chains from the proteoglycan protein and renders 
the CSPGs molecules inactive. The injection of chondroitinase ABC leads to an 
improvement in axon regeneration as well as functional recovery after CNS injury (D. 
Crespo et al., 2007). The premise underlying these experiments is that injecting the 
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ChABC led to the degradation or digestion of CSPGs in the glial scar, therefore reducing 
the inhibitory activity of the external environment to regenerative axonal sprouting (J. M. 
Massey et al., 2006).  
 
1.4.2 Myelin, a Major Inhibitory Component Presence in CNS 
Apart from CSPGs, Myelin-associated inhibitors (MAIs) are another class of important 
proteins that exert inhibitory effect upon regenerative axonal outgrowth in the injured 
CNS. The MAIs are associated with myelin, which is produced by oligodendrocytes. 
Myelin is the lipid-rich multilayer membrane that enwraps axons, and creates different 
axonal segments referred to as the internode (Node of Ranvier). The MAIs consist of 
several major proteins including Nogo-A, myelin-associated glycoprotein (MAG), and 
oligodendrocyte myelin glycoprotein (OMgp) (as reviewed by E. A. Huebner and S. M. 
Strittmatter, 2009). Among these MAIs, Nogo-A has been shown to inhibit axon 
regeneration after lesioning of the CNS in adult rats (as reviewed by E. A. Huebner and 
S. M. Strittmatter, 2009).  Furthermore, antibodies against Nogo-A, IN-1, have been 
shown to improve the contralateral forepaw function in rats that received an ischemia-
induced cortical lesion at the right hemisphere of the cortex an experimental ischemic 
stroke model (C. Wiessner et al., 2003; A. B. Seymour et al., 2005). Interestingly, most of 
the MAIs are not found in the PNS, except for MAG (PNS-specific MAG). However, 
both CNS and PNS myelin have been reported to be inhibitory to neurite growth of both 
PNS and CNS axons in vitro (S. Hirsch and M. Bahr, 1999)). Hence the presence of 
MAIs alone may not be sufficient to explain the difference in regenerative capacity 
between injury CNS and PNS in vivo. However, several studies have proposed that the 
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different rate of clearance of myelin debris following injury to the PNS and CNS may 
contribute towards this difference. The clearance of myelin debris is primarily achieved 
by inflammatory microglia and macrophages (as reviewed by E. A. Huebner and S. M. 
Strittmatter, 2009;S. Hirsch and M. Bahr, 1999), which will be further discussed in the 
next section.  
 
1.5 Inflammatory Cells Response After Injury in Both CNS and PNS 
One of the important cellular and molecular components of the injury site in both CNS 
and PNS is the inflammatory response, which is primarily mediated by microglia and 
macrophages that rapidly migrate to the site of injury. Both of these cells also participate 
actively in the phagocytosis of cellular and myelin debris, as well as secreting cytokines 
and other inflammatory factors in response to injury. It should be noted that during injury 
both the resident inflammatory cells (i.e. microglia in CNS and macrophages in PNS) as 
well as those perivascular macrophages that migrate into the injured brain contribute to 
the inflammatory response. However this review will focus primarily upon the actions of 
the resident inflammatory cells, as these are the best characterized in post-injury 
situations.  
 
1.5.1 Microglia Response After CNS Injury 
Microglia are the resident immune cells present in the CNS. Similar to astrocytes, in 
response to injury microglia rapidly undergo a change in morphology, from ramified to 
ameboid structure, which is commonly known as the “activated” form of microglia (J. A. 
Amat et al., 1996;F. Gonzalex-Scarano and G. Baltuch, 1999).  
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In their ramified morphology under basal physiological condition, microglia rapidly 
extend and retract processes, actively ”scanning” the external environment for 
abnormalities (D. Davalos et al., 2005). In response to injury, microglia undergo a rapid 
series of changes, becoming “reactive”. These changes involve an increase in dynamic 
movement and hypertrophy of their processes. Reactive microglia extend their processes 
towards areas of trauma, forming a “barrier” around the injury induced by either laser 
with two–photon microscopy or needle-stick stab injury in the brains of adult rats (J. A. 
Amat et al., 1996; D. Davalos et al., 2005). Furthermore, this change in phenotype also 
occurs over a spatial and temporal gradient, with microglia nearest to the injury site first 
to develop an ameboid morphology, follw by a shift in morphology in neighbouring 
microglia radiating outwards away from the injury site over time (J. A. Amat et al., 
1996). Subsequent studies have demonstrated that ATP (adenosine triphosphate) released 
from injured neurons is one of the triggers for these rapid morphology change in 
microglia (D. Davalos et al., 2005). The “barrier” formed by reactive microglia is 
believed to act as a cellular and molecular boundary that limits the spread of cell death 
from the lesion site. It has been shown that reactive microglia inhibit neurite outgrowth as 
well as causing neurite retraction in vitro (G. Münch et al., 2003). Therefore, it is 
generally considered that the barrier formed by reactive microglia also contributes to the 
formation of the inhibitory glial scar following CNS injury.  
 
In response to injury, microglia rapidly respond by re-orientating their processes towards 
and migrating to the injury site. This has been demonstrated in rat hippocampal slice 
cultures in vitro (maintained for 1-7 days), where a slice injury was performed and 
 14 
resulted in an immediate microglial response, including increased motility (chemotatic 
activity) towards the injury site (M. A. Petersen and M. E. Dailey, 2004). Studies have 
identified that the chemotactic behavior of microglia can be stimulated by ATP, an 
intracellular factor that is rapidly and transiently elevated in the extracellular space 
following CNS injury. Using transgenic mice bearing a GFP-transgene under a microglia-
specific promotor, local release of ATP induced by a microelectrode inserted into the 
cortex led to a rapid microglial respond similar to that observed after the application of 
laser ablation (D. Davalos et al., 2005). This chemotactic effect of ATP upon microglia 
has also been observed in vitro, with the application of both ATP and adenosine 
diphosphate (ADP) inducing chemotaxis in microglia culture (S. Honda et al., 2001). 
Application of inhibitors (such as pertussin toxin) into microglia cultures have further 
identified that the chemotactic response observed in microglia is regulated in a P2Y-
receptor dependent manner (S. Honda et al., 2001).  
 
Another important function of reactive microglia within the injured brain is phagocytosis.  
This has been demonstrated in live imaging experiments undertaken on corpus callosum 
brain slices, revealing that activated microglia rapidly migrate towards the injured surface 
(within minutes) and phagocytose dead or damaged cells and debris (J. Brockhaus et al., 
1996). Furthermore, studies using hippocampal slice culture maintained for 7 days have 
demonstrated that the phagocytic behaviour of microglia is a regulated process, with 
microglia selectively phagocytosing cells that undergo apoptosis) (M. A. Petersen and M. 
E. Dailey, 2004).  
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1.5.2 Macrophage Response After PNS Injury 
Similar to microglia in the CNS, macrophages undergo similar responses to injury in the 
PNS, including changes in morphology, chemotactic responses towards sites of injury, as 
well as production of cytokines and other inflammatory factors. There are two major 
pools of macrophages in the PNS; a small pool of resident macrophages within peripheral 
nerves, and a larger population of macrophages present in the blood. (M. Muller et al., 
2010). Macrophages (both blood-borne or resident) have an important role after PNS 
injury, when they rapidly respond by upregulating the expression of pro-inflammatory 
cytokines including IL-1 (interleukin-1), IL-6 (interleukin-6) and TNFα (Y. Murata et al., 
2004). Furthermore, reactive macrophages also upregulate the expression of neurotrophic 
factors such as BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) 
in response to injury (A. Salegio et al., 2011). Interestingly, reactive macrophages can 
modulate inflammation by producing anti-inflammatory cytokines as well as inducing T-
cell apoptosis (reviewed in Y. Murata et al., 2004). Together, these studies demonstrate 
that macrophages have an important role in modulating the inflammatory response after 
injury. Macrophages also participate in phagocytosis of myelin and cell debris after 
injury, especially in response to Wallerian degeneration (W. Brück et al., 1994).  
 
1.5.3 Are Microglia / Macrophages Beneficial or Harmful to CNS / PNS Injury?  
Overall, studies have demonstrated that microglia and macrophages have both harmful 
and protective functions in response to peripheral and central injury. Recent studies have 
revealed that there are two major functional subtypes of macrophage activation in 
response to injury. These are referred to as M1, which are the neurotoxic and 
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proinflammatory macrophages, and M2, which are non-neurotoxic and anti-inflammatory 
macrophages (K. A. Kigerl et al., 2009). Both microglia and macrophages have been 
demonstrated to be able to interchange between these two phenotypes in response to 
different cytokines. Hence, IFN-γ (Interferron-γ) and IL-12 (Interleukin-12) lead to the 
formation of the M1 phenotype, while, IL-4 (Interleukin-4) and IL-0 (Interleukin-10) are 
associated with the formation of the M2 phenotype (R. D. Stout et al., 2005). In vitro, M2 
macrophages have been shown to not only support neuronal growth but also facilitate 
neuritic outgrowth to overcome the presence of growth inhibitory substrates (K. A. Kigerl 
et al., 2009). Because of these different functions, it has been proposed that the M1:M2 
macrophage ratio is an important contributor to the rate of nerve regeneration after injury 
(K. A. Kigerl et al., 2009).  
 
1.6 Schwann Cells Make a Major Contribution to the Permissive Environment that 
Support Axonal Sprouting After Injury in PNS  
It is striking that the PNS is substantially more capable of undergoing a successful neural 
regenerative neural response than the injured CNS. This appears to be primarily mediated 
by the relative permissiveness of the extracellular environment of the injured PNS to 
nerve regeneration versus the strongly inhibitory environment of the injured CNS.  
One of the seminal examples of the permissiveness of the PNS to neural regeneration 
were studies using peripheral nerve grafts transplanted into the injured spinal cord. 
Studies of this type have demonstrated that the different regenerative capacity between 
CNS and PNS is largely due to the difference in structure and composition of the 
extracellular matrix (D. Muir, 2010). David, S. and Aguayo, A.J. (1981), were the first to 
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demonstrate that considerable amounts of regenerative axonal sprouting from the injured 
spinal cord could be induced by the transplantation of a segment of the sciatic nerve into 
the completely transected spinal cord to act as a structural “bridge” between the cut ends 
of the spinal cord. Importantly, regenerating spinal axons growing through peripheral 
nerve grafts have been reported to form functional connections with target neurons (P. 
Gauthier et al., 2002). Therefore, these studies demonstrate that if the appropriate 
extracellular environment was provided, central neurons are able to successfully 
regenerate after injury (Review by S. Hirsch and M. Bahr, 1999).   
 
One of the major contributing factors to the permissive environment of the PNS to nerve 
regeneration is thought to be provided by Schwann cells.  Schwann cells are the major 
glial cell within the PNS, and have important roles in both development as well as 
stressful situations. In some regards, Schwann cells perform the collective functions that 
astrocytes and oligodendrocytes perform in the CNS.  Schwann cells are involved in 
myelinating peripheral nerves, as well as regulating the extracellular environment within 
the PNS through the production of neurotrophic factors and chemokines (Kalichman, 
1998).  Schwann cells can generally be divided into two distinct classes based upon these 
functions, myelinating and non-myelinating Schwann cells present depending upon the 
extrinsic signal received from surrounding axons. Non-myelinating Schwann cells 
associate with small caliber axons, while myelinating Scwann cells ensheath large caliber 
axons (R. Mirsky and K. R. Jessen, 1999). Schwann cells are also involved in producing 
the basal lamina, a layer of extracellular matrix that forms the endoneurial tubes that 
ensheath both Schwann cells and the surrounding peripheral nerve (J. W. Fawcett and R. 
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J. Keynes, 1990). The basal lamina is mainly composed of laminin, collagen type IV and 
heparan sulfate proteoglycan. The basal lamina is considered a permissive substrate to 
axonal growth and guidance (as reviewed in S. Hirsch and M. Bahr, 1999; R. Mirsky and 
K. R. Jessen, 1999). The importance of basal lamina in post-injury regeneration has been 
demonstrated following sciatic nerve crush injury, which does not result in loss of the 
basal lamina. Axonal regeneration is faster following crush injury as opposed to complete 
sciatic nerve transection. This has been attributed to the intact basal lamina in the crush 
injury, which acts as a permissive structural and molecular support for regenerating 
axons. This is in contrast to complete transection of the sciatic nerve where the basal 
lamina was also damaged, which resulted in regenerative axonal sprouting that appeared 
to occur in an unguided manner (as reviewed by A. J. Sumner, 1990; D. Tonge et al., 
1997).  
 
After injury, Schwann cells have a major modulatory role in Wallerian degeneration, by 
initially phagocytosing myelin debris which then led to the secretion of chemoattractant 
molecules by Schwann cells to stimulate macrophages recruitment (U. M. Liu et al., 
1995). The recruited macrophages then continued to phagocytose the degenerating axons 
as well as the surrounding myelin debris (O. A. R. Sulaiman and T. Gordon, 2009). In 
response to injury, Schwann cells can undergo de-differentiation, reverting to a non-
myelinating phenotype, which facilitates their activity in guiding regenerating axons in 
the endoneurial tubes. The Schwann cells that line the inner side of the basal lamina also 
provide structural support to guide regeneration of the axons as well as providing trophic 
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support through production of various neurotrophic factos such as laminin (S. Hirsch and 
M. Bahr, 1999; O. A. R. Sulaiman and T. Gordon, 2000).  
 
1.7 Permissive VS Nonpermissive Environment for Axonal Sprouting After Injury 
The balance between the permissive and nonpermissive extracellular environment has a 
major role in contributing to the overall regeneration rate in axons after injury in both 
PNS and CNS. For further comparison of the factors that affect the permissivity of the 
environment to regeneration between the CNS and PNS refer to Table 1.1 attached 
below. Treatment strategies for CNS injury have been focused in modulating the 
permissiveness of the environment, such as the usage of chondroitinase as well as IN-1, 
which target specific inhibitory components present in the injury site. This thesis focus 
mainly upon the neuroprotective protein, metallothionein, which has been shown 
previously to have a neuroprotective effect directly upon central neurons after injury, as 
well as to act on glial cells to modulate their injury response.  
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Table 1. Summary of the Factors that Contribute to the Different Regenerative 
Rates Following Injury in Both CNS and PNS.  
This table summarizes the factors that contribute to the different regenerative outcomes 
observed following injury in CNS and PNS. These differences mostly contribute to the 
different permissivity of the extracellular environment to nerve regeneration.  
 
1.8 Role of Metallothionein in Neuron Regeneration 
Metallothioneins (MTs) are a family of low molecular weight (6-7kDa) metal binding 
proteins, which consist of two domains (α- and β). The protein structure is characterized 
by a highly conserved cysteine content (20 cysteine residues across all mammalian 
isoforms) (reviewed by J. Hidalgo et al., 2001; P. Coyle et al., 2002). There are 4 
isoforms of MT in mammalian species, which have different tissue distribution in the 
body. Briefly, MT-I and -II have high sequence homology and appear to be ubiquitously 
Central Nervous System Peripheral Nervous System 
(CNS) (PNS)
Neurons Intrinsic Growth Rate Slow upregulation of Fast upregulation of 
regenerative-associated regenerative-associated
gene gene
(Bisby and Tetzlaff, 1992) (Huebner and Strittmatter, 2009)
Glial Response Astrocytes Schwann Cells
Production of CSPGs Secrete growth promoting
Associate with glial factors e.g. laminin 
scar formation Produce basal lamina 
(Hirsch and Bahr, 1999) (Hirsch and Bahr, 1999)
Myelin Composition Oligodendrocytes Schwann Cells
Contain MAIs (include Contain PNS specific MAG
MAG, NogoA, Omgp)
(Silver and Miller, 2004) (Sulaiman and Gordon, 2009)
Clearance of myelin and Microglia Macrophages
cellular debris Slower and incomplete Fast clearance
clearance
(George and Griffin, 1994) (George and Griffin, 1994)
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expressed throughout the body (e.g. brain, liver, kidney). In contrast, MT-III is primarily 
expressed in the brain, while MT-IV is mostly expressed in squamous epithelial tissue 
(for further review refer to (A. T. Miles et al., 2000; J. Hidalgo et al., 2001; P. Coyle et 
al., 2002). This section will primarily discuss the action of MT-I and-II in promoting 
repair of injured neurons, which will be the main focus of this study.  
 
Metallothionein I/II (hereafter referred to as MT) has been shown in a number of studies 
to confer protection to injured neurons both in vitro and in vivo. It has previously been 
reported that application of exogenous MT-IIA (the major MT form expressed in the 
mammalian brain) into the lesion site following focal needle stick injury to the adult rat 
neocortex led to preservation of tissue damage (characterised by a smaller lesion volume) 
and an increase in regenerative axonal sprouting compared to vehicle-treated animals (R. 
S. Chung et al., 2003). Furthermore, the exogenous application of MT also improved the 
initial neurite outgrowth response in dissociated cortical neuronal culture in vitro (R.S. 
Chung et al., 2003). It has been identified that MT also has a major role in the cellular 
interaction between astrocytes and neurons after injury, where Chung et al. (2004) have 
demonstrated that the MT expression was upregulated and secreted by astrocytes in 
response to neuronal injury both in vitro and in vivo (R.S. Chung et al., 2004). MT also 
appeared to have a role in regulating the response of astrocytes after neuronal injury. In 
which, the addition of MT in culture media of cultured astrocytes has led to an alter 
activated morphology as well as decrease in CSPGs expression, hence providing a more 
permissive environment which support the growth of neurites in vitro (Y.K. Leung et al., 
2009).  
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The importance of the endogenous MT could be further demonstrated in studies where a 
cryolesion cortical injury was applied in MT-deficien mice. In this study, cryolesion led 
to substantially greater tissue damage in MT-deficient mice in comparison to wild type 
mice (M. Penkowa et al., 1999). Furthermore, a significant delay in astrogliosis and 
microgliosis was also observed in the cryolesion-injured MT-deficient mice when 
compared to the wild type mice (M. Penkowa et al., 1999). To further demonstrate the 
ability of MT to protect neurons against trauma, genetic overexpression of MT-II in 
transgenic mice leads to substantially improved recovery in motor function after focal 
cerebral ischemic damage in comparison to wild type mice (M. van Lookeren Campagne 
et al., 1999). In summary, these studies demonstrate that MT is capable of improving 
neuronal survival and recovery following various types of experimental traumatic brain 
injury.  
 
Recently, evidence has emerged identifying a specific molecular pathway through which 
MT can promote survival and regeneration of injured neurons. In several studies, it has 
been shown that the megalin receptor (low-density lipoprotein receptor-related protein -1, 
LRP1) is directly involved in the molecular signaling pathway underlying the neuro-
protective effect of MT (M. Fitzgerald et al., 2007; R. S. Chung et al., 2008). Chung et al 
(2008) reported that the megalin receptor is responsible for uptake of MT into cultured 
cortical neurons, and that uptake is required for neuritogenic activity. Furthermore, 
siRNA-mediated knockdown of megalin expression blocked the ability of MT to promote 
initial neurite outgrowth in vitro (R. S. Chung et al., 2008). More recently, an artificial 
peptide comprised of a small section of the native β-domain of MT-II, named Emtin B, 
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has been shown to promote neurite outgrowth in primary cerebellar granule neuron 
cultures in a similar manner to native MT via interaction with the megalin receptor (M. 
Ambjorn et al., 2008). Overall studies using different neuronal models suggested that 
megalin is an important component in the signaling pathway through which MT or Emtin 
B are able to promote neurite outgrowth of CNS neurons.  
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1.9 Aims of This Project 
This project will characterise some of the mechanisms that regulate the ability of 
exogenous MT to promote axon regeneration after injury. Prior studies have shown that 
MT directly promotes regenerative axonal sprouting after brain injury. However the 
precise mechanisms underlying this effect remain unknown. Aim 1 of this project is to 
investigate whether exogenous MT interacts directly with neurons in the injured brain to 
promote regenerative sprouting, and whether this involves interaction with low-density 
lipoprotein receptors such as megalin. As part of the findings, it was surprisingly found 
that MT might also indirectly promote regenerative axonal sprouting in the injured brain 
via modulation of the microglial response to traumatic brain injury.  Therefore, Aim 2 of 
this study was to investigate the effect of exogenous MT upon reactive microglia, with 
particular focus upon whether exogenous MT alters the permissivity of reactive microglia 
to facilitate nerve regeneration after injury.  
 
Interestingly, a recent study has identified the presence of megalin, the putative MT 
receptor, in dorsal root ganglion neurons. Therefore, the second part of this study was to 
investigate whether MT also exerts neuroprotective properties upon injured peripheral 
neurons. To investigate this, cultures using DRG neurons will be used, where exogenous 
MT will be applied to injured neurons to investigate what effect exogenous MT might 
have on DRG neurons after injury.  
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Aim 1. To identify the molecular mechanism through which exogenous MT promotes 
regenerative sprouting in cortical neurons after injury.  
Aim 2. To investigate how MT might influence or potentially modulate the microglial 
response after CNS injury.  
Aim 3. To investigate whether MT promote peripheral nerve regeneration, and whether 
this involves signaling through low-density lipoprotein receptors 
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Chapter 2 Defining the Molecular Mechanisms Underlying the Ability 
of MT to Promote Regeneration of Injured Cortical Neurons  
2.1 Introduction 
The precise mechanism/s through which exogenous MT promotes improvement in 
regenerative axonal sprouting when injected directly into the injured CNS remains 
unclear. Some insight has been gained from studies utilising tissue culture models, which 
have clearly demonstrated that exogenous administration of MT acts directly upon 
neurons to modulate neurite growth. Studies have shown treatment with MT promotes 
neurite sprouting and elongation when applied to either cortical neurons or retinal 
ganglion cells immediately after initial plating in culture (R. S. Chung et al, 2003; M. 
Fitzgerald et al, 2007). Importantly, tethering of MT to an artificial substrate prevents 
MT-mediated improvement in neurite outgrowth, indicating that uptake of MT is required 
for this action (R. S. Chung et al, 2008). Neuronal uptake of MT appears have also shown 
to be mediated through interaction with low-density lipoprotein receptors (LRPs), and in 
particular LRP2 (also known as megalin) (R. S. Chung et al, 2003; M. Fitzgerald et al, 
2007). Hence, siRNA knockdown of megalin expression completely blocks the uptake of 
exogenous MT into cultured cortical neurons, and subsequently blocks the ability of MT 
to promote neurite outgrowth (R. S. Chung et al., 2008). However, neurons are known to 
express a range of LRP receptors, which are known to response to other neuritogenic 
protein, such as Apo-E (apolipoprotein E) which promotes neurite extension (Z. Qiu et 
al., 2004). Therefore, whether MT acts via one or more LRP receptors to promote axonal 
regeneration in the injured CNS in vivo remains to be elucidated.  
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To date, the evidences that MT can promote neural regeneration of cortical neurons is 
based upon two primary observations; i) injection of MT into the injured cortex promotes 
substantial regenerative neurite sprouting and ii) in cell culture, exogenous addition of 
MT into the culture medium promotes regenerative neurite sprouting of axotomised 
cortical neurons. The goal of this chapter is to investigate whether MT acts directly upon 
injured cortical neurons to promote their regeneration following injury to the neocortex in 
vivo.  This was undertaken by injecting fluorescently-labeled MT into the injured cortex, 
which allow the visualisation of MT distribution and uptake after injury. Furthermore, the 
same injury model was also used to study the involvement of megalin in MT-mediated 
axonal regeneration. 
 
2.2 Materials and Methods 
2.2.1 MT Protein Labeling 
MT was fluorescently tagged using the AlexFluor® 488 Protein Labeling Kit (Invitrogen). 
Overall the procedures followed the accompanying instruction manual. In short, 1M of 
sodium bicarbonate was prepared by adding 1mL of deionised water to the vial provided 
with the kit (containing sodium bicarbonate), and 50µL of this was then added to a 
500µL volume of 2mg/mL MT (Bestenbalt; resuspended in 0.7% saline to final 
concentraion at 2mg/mL, filter sterilized prior used). The protein mixture was then added 
to the provided tube containing the reactive dye (warmed up to room temperature prior 
used) and fully mixed by inverting the vial several times. The vial was then mixed further 
using the magnetic stirrer bar provided in the kit at room temperature for 1 hour. The 
separation column was then assembled using a clamp to hold it in upright position. The 
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purification resin was then mixed thoroughly to ensure homogeneous suspension using 
the pipette provided in the kit, and the resin was then transferred into the column, 
ensuring no bubbles were formed as the formation of bubbles may interrupt the flow. The 
reaction mixture containing the tagged protein was then loaded into the column and the 
reaction vial rinsed with 100µL of the elution buffer and loaded onto the column. More 
elution buffer was then continually added into the column until the labeled protein 
(hereafter referred as 488-MT) had been eluted. During the elution process, all of the 
eluted fractions were collected including the unincorporated dye (second band that eluted 
later than the tagged protein, hereafter referred as AlexaFluor-488), which was 
subsequently used as the vehicle treatment for later experiments.  
 
2.2.2 Focal-cortical Brain Injury in Adult Rat 
All animal experimentation was performed under the guidelines stipulated by the 
University of Tasmania Animal Ethics committee, which is in accordance with the 
Australian code of practice for the care and use of animals for scientific purposes. Adult 
Sprague Dawley rats (weight range from 180 - 220g; N=3 per treatments) were first 
anaesthetised in a gas chamber filled with isoflurane (AttaneTM, Bomac). An anti-
inflammatory drug, Meloxicam (150µL MetacamTM, Boehringer Ingelheim), was then 
administered intraperitoneally. Following the injection, the scalp of the animal was 
shaved, and the head immobilised in the stereotactic frame using two ear bars. 
Continuous anaesthesia was maintained with 2.5% isoflurane at 0.7 lpm using a Kopf gas 
mask. The shaved scalp was cleaned using alcohol wipes (WebcolTM, Kendall) and a 
surgical incision through the skin overlying the skull was then made using a surgical 
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blade (No.10, Swann-Morton) down the midline. This exposed the skull, and a dental 
drill (Foredom) was then used to carefully drill through the skull on top of the target 
region (5mm anterior, 4.5mm lateral from lambda). A Hamilton syringe was used to 
stereotactically deliver the different treatments (488-MT, 2mg/mL or AlexaFluor-488; 
Saline, MT 1mg/mL, MT 1mg/mL+RAP (Receptor Associated Protein from 
Progen;1mg/mL); volume of injection for all treatments was 1µL). The injury was 
created by lowering the needle 1.5mm from the surface of the cortex, and the needle was 
left within the injury site for 10 minutes. After the first 5 minutes, 0.5µL of the treatment 
solution was injected into the injury site. After a further 5 minutes, the needle was raised 
by 0.5mm and the remaining 0.5µL of the treatment solution was then injected into the 
cortex. The injury site was closed with Gelfoam (pre-soaked with the appropriate 
treatment solution). The skin was then pulled back together and sutured (N502 Nylene, 
Dynek Pty Ltd). Rats were then allowed to recover in their cages. Both the weight and the 
movement of the rats were monitored for the next 4 days until experimental endpoint. No 
rats were observed to be in any distress during this period. 
(For details of the experimental setup, please refer to Figure 2.1) 
 
2.2.3 Perfusion and Processing on the Cortical Brain Samples 
Four days after the injury, the rats were anaesthetised using a gas chamber filled with 
isoflurane gas, followed by an intraperitoneal injection of Ilium Pentobarbitone (4mg/g of 
animal weight) to induce deep anaesthesia. Cardiac perfusions were then performed, with 
200 mL ice cold PBS (phosphate buffer salin; Medicago, Sweden) followed by 200 mL 
4% paraformaldehyde. The brain was then removed from the rats and post-fixed in 4% 
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paraformaldehyde, 4% sucrose solution for 24 hours, followed by immersion in 10% 
sucrose for 24 hours and a subsequent 24 hours incubation in 30% sucrose solution. The 
brains were then embedded in OCT (optimal cutting temperature; Thermo Scientific) and 
cryosectioning undertaken using Leica CM1850 Cryostat, 16µm sections were then 
collected onto APTS (3-aminopropyltriethoxysilane)-treated microscopy slides.  
(For details of the experimental setup, please refer to Figure 2.1) 
 
2.2.4 Immunohistochemistry on Frozen Cortical Brain Sections 
The frozen sections were first incubated with PBS for 5 minutes. The PBS was then 
removed and replaced with primary antibodies (Mouse anti SMI312 from Covance use at 
1:1000; Rabbit anti Iba-1 from Wako, use at 1:500; Rabbit anti Ferritin from Abcam, use 
at 1:1000; Mouse anti MT from Dako use at 1:1000; Rabbit anti LRP1 from Sigma-
Aldrich, used at 1:1000; Rabbit anti Megalin from Santa Cruz Biotechnology, used at 
1:1000) diluted in immunohistochemistry diluent (PBS + 0.03% Triton-X) and incubated 
at 4°C overnight. Unbound primary antibodies were then removed with three PBS washes 
(5 minutes incubation per wash at room temperature). The secondary antibodies 
(AlexaFluor 594 anti mouse from Invitrogen used at 1:1000; AlexaFluor 594 anti Rabbit 
from Invitrogen used at 1:1000; AlexaFluor 488 anti mouse from Invitrogen used at 
1:1000) were diluted in PBS and applied for 1 hour at room temperature. Unbound 
secondary antibodies were then removed with three PBS washes (5 minutes incubation 
per wash at room temperature) and the sections then incubated with Nuclear Yellow 
(1µg/mL) for 5 minutes at room temperature follow by two PBS washes (5 minutes per 
wash). The sections were permanently mounted onto glass slides using fluorescent 
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mounting agent (Dako). Digital images from the sections were then visualised and 
captured using standard fluorescence microscope (Leica DM LB2) with mounted camera 
(Olympus Magnifire cooled-CCD camera) and a two-photon confocal microscope (Zeiss 
LSM 510).  
 
Furthermore, to ensure that the antibody used in these study does not led to any auto-
fluorescence, several control were performed. The no secondary antibodies control were 
performed by incubating the primary antibodies (GFAP, Iba-1 and SMI312) but used 
PBS instead of secondary antibodies. Using PBS as the primary antibodies and the 
secondary antibodies (Alexa-Fluor 488 anti mouse and Alexa-Fluor 594 anti rabbit) as 
the no primary antibodies control (Figure 2.2). All controls undergo same staining 
procedures as stated previously. 
 
2.2.5 Measurement of Lesion Volume in Brain Sections.  
The frozen sections collected from both the AlexaFluor 488 and 488-MT-treated animals 
(9 sections per treatments) were immunolabeled with SMI312 antibody using protocol 
stated in Section 2.2.4. The area of the lesion site was then traced and measured using 
Photoshop CS3. (Abdobe) software. The results were analysed statistically with t-test, 
where p<0.05 considered as significant.  
 
2.2.6 Quantification of Regenerative Sprouting in Brain sections 
The tissue sections were immunolabeled with SMI312 and ferritin antibodies as 
described in previous sections. Two or three digital images were captured along the 
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injury site per section (3 sections in total for each treatment, i.e. vehicle, MT, MT+RAP) 
using a Leica DM LB2 microscope and Olympus magnifire cooled-CCD camera. The 
lesion site was identified by ferritin labeling, and all SMI-312 immunolabeled processes 
overlapping with ferritin positive cells were automatically traced using HCA-Vision 
(CSIRO) neurite tracing software. The sum of all traced neurites was calculated, and for 
each experimental group is described as a percentage ratio relative to vehicle-treated 
animals.  
 
2.3 Results 
2.3.1 Treatment with 488-MT Leads to a Decrease in Overall Injury Size After Focal 
Cortical Brain Injury  
Injections of 1µl of either 488-MT or AlexaFluor-488 (vehicle treatment) were made at 
the time of cortical needlestick injury in adult rat brains. Four days after injury, 16µm 
cryostat sections were prepared and immunohistochemistry staining was undertaken with 
the SMI-312 antibody (labels phosphorylated neurofilaments). This timepoint was 
selected for these studies, as it corresponds with the time at which regenerative sprouting 
can be observed following this type of injury (C. E. King et al., 2001; R. S. Chung et al., 
2003). It was found that 488-MT injection resulted in a comparatively smaller injury size 
compared to the vehicle treatment (marked by white line in Figure 2.3). Quantitative 
measurements of the lesion site confirmed that MT treatment caused an approximate ten-
fold decrease in lesion area in comparison to the vehicle treatment (2.2x104µm2 vs 
2.1x105µm2; p<0.01). Notably, in the injury site of AlexaFluor-488 treated animals, the 
appearance of axons within and bordering the injury site was considerably granular and 
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fragmented, indicative of degenerative processes, in accordance with previously 
published (C. E. King et al., 2001). However, within the injury site of 488-MT treated 
animals, numerous regenerative processes (distinguishable by intense SMI-312 labeling 
and morphology) were observed sprouting into the injury site (Figure 2.3). These results 
indicate that 488-MT is capable of promoting a neuroregenerative response in the injured 
cortex comparable to the unlabeled MT protein as has been reported previously (R. S. 
Chung et al., 2003).  
 
2.3.2 Neuronal Localization of 488-MT Within the Injured Brain 
Using high-resolution confocal microscopy, there was a distinct increase in regenerative 
axonal sprouting caused by 488-MT injection (Figure 2.5) in comparison to the vehicle 
treatment (Figure 2.4). Furthermore, in AlexaFluor-488 dye injected animals, there 
appeared to be no neuronal uptake of the fluorescent AlexaFluor-488 (Figure 2.4). 
However, most of the AlexaFluor-488 appeared to have accumulated in non-neuronal 
cells present within the injury site (Figure 2.4). Z-stack confocal images were collected 
through the depth of the tissue section, and used to confirm that there was no co-
localisation between the SMI312 staining and the AlexaFluor-488 (indicated by arrow in 
Figure 2.4).  
 
Noticeably, in 488-MT injected animals, there appeared to be some co-localisation 
between 488-MT and SMI-312 labelled neuritic processes (Figure 2.5).  The intensity of 
the 594 laser was decreased and increased to two extremes, and this did not alter the 
fluorescent 488 signal, indicating that there was no cross-over between the two 
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fluorescent signal responsible for this co-localisation. The presence of 488-MT within 
SMI-312 labelled neuritic processes was confirmed in the Z-stack confocal images 
(indicated by arrow in Figure 2.5).  
 
Some sections were also immunolabeled using MT antibodies, which demonstrated that 
there was no co-localization between the MT labelling with the AlexaFluor 488, 
However, co-localisation was observed between the MT and the 488-MT. This strongly 
suggests that most of the green fluorescent signal is 488-MT and not AlexaFluor-488 that 
has become detached from the MT (Figure 2.6).  
 
2.3.4 MT Promotes Regenerative Axonal Sprouting Via a LRP-Dependent Pathway 
Prior in vitro studies have reported that MT promotes initial neurite ougrowth of cultured 
cortical neurons through interaction with megalin (also known as LRP2) (R. S. Chung et 
al., 2008). To investigate whether interaction with megalin or other LRP receptors is 
required for MT to promote regenerative sprouting in vivo, experiments were undertaken 
with administration of either saline (vehicle treatment), MT alone (1mg/mL), or MT 
together with RAP (injected together in one single injection). RAP is a competitive ligand 
for LRP receptors (including both LRP1 and megalin) that is routinely used 
experimentally to antagonise and block the activation of LRP receptors (A. Lazic et al., 
2006). In this experiment, it was found that injection of MT alone led to a substantial 
increase in regenerative axonal sprouting after injury (Figure 2.8) in comparison to the 
saline (Figure 2.7) and MT with RAP (Figure 2.9) treatments. High magnification 
confocal stack images were collected along the edges of the lesion site (using confocal 
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microscopy and serial images collected through the z-axis), and revealed that in MT-
treated animals, regenerative axonal sprouting was observed in close association with 
ferritin-immunoreactive inflammatory cells (microglia and/or macrophages; Figure 2.8). 
This was in contrast with both the vehicle and MT + RAP treatments, in which there was 
substantially less regenerative axonal sprouting, and limited association between 
regenerating axons and microglia (Figure 2.7 and 2.9 respectively). This was particularly 
apparent in animals that received the MT + RAP treatment, with the majority of axons 
present along the injury site either fragmented or disintegrated (Figure 2.9B-E). The 
ability of RAP to completely abrogate MT-mediated regenerative axonal sprouting 
suggests that an interaction with LRP receptors is important. The amount of regenerative 
sprouting observed along the injury site border was measured and quantitated and the 
results further support the notion that addition of MT improved regenerative neurite 
sprouting significantly compared to vehicle treatment (Refer to Figure 2.10).  
 
The uptake of MT by microglia, and the close association between regenerative sprouts 
and reactive microglia in MT treated animals hint at an unexpected action of MT upon 
microglia to facilitate wound healing. This will be investigated further in the next 
chapter.  
 
2.3.5 The Expression Pattern of LRPs in Cortical Neurons In Vivo 
Immunohistochemical labelling using antibodies against LRP1 and megalin (LRP2) was 
performed in vehicle-treated brain sections. The majority of the megalin labeling was 
found to co-localise with axons (co-labeled with SMI312). However, the majority of 
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LRP1 labeling was not co-localised with axons but glial cells within the core of the injury 
site. Notably, LRP-labeled cells bear a similar morphology to microglia as described in a 
previous section (Refer to Figure 2.11).   
 
2.4 Discussion 
Overall this study has demonstrated that after injury, exogenously administered MT 
accumulates in some neurons, and leads to substantial reduction in lesion volume and 
improvement in regenerative axonal sprouting into the injury site. Interestingly, most 
488-MT appeared to accumulate in Iba-1 labeled inflammatory cells, suggesting that MT 
might also have effects upon these cells. This will be explored further in the next chapter.  
 
The key finding of this chapter is that exogenously administered 488-MT is internalised 
by some cortical neurons following needlestick injury, and that co-treatment with RAP is 
able to completely block MT-mediated regenerative axonal sprouting. In accordance with 
prior in vitro studies, this suggests that exogenous MT interacts directly with neurons 
through LRP receptors to promote regenerative sprouting in the injured neocortex.  
Hence, studies have reported the internalisation of MT by cultured cortical neurons via 
megalin and that this promotes initial neuritie outgrowth after plating (R. S. Chung et al., 
2008). One of the limitations of this study is that RAP blocks both LRP1 and megalin 
receptors, meaning that it is not possible to conclusively determine which LRP receptor 
(or both) is involved in mediating MT’s regenerative action. However, several studies 
suggest that megalin may be the primary target for MT. Surface Plasmon resonance 
studies have demonstrated that MT has a 100-fold higher binding affinity to megalin than 
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LRP1 (M. Ambjorn et al., 2008). Furthermore, specific siRNA knockdown of megalin 
expression in cultured cortical neurons almost completely blocked MT uptake and MT-
mediated promotion of neurite outgrowth in vitro (R. S. Chung et al., 2008). Notably, in 
this chapter, only megalin (and not LRP1) labeling was observed in some neuritic 
processes along the edge of the injury tract. This suggests that megalin may be primarily 
responsible for mediating MT-signalling in injured neurons. However, both LRP1 and 
megalin were expressed in the glial cells within the central lesion cavity, suggesting that 
these cells may also be responsive to exogenous MT. This will be investigated in the next 
chapter. 
 
The logical next step to evaluate whether MT promotes cortical neuron regeneration via a 
LRP- and MAPK-depedent mechanism would be to use purified cortical neuron cultures.  
These experiments were undertaken concurrently to this PhD thesis by Assoc. Prof. 
Roger S Chung (who undertook the injury experiments, and post-injury quantitative 
analysis of regenerative sprouting, and western blotting), with assistance by Jaqueline 
YK Leung (who prepared the neuronal cultures, and performed the immunostaining). As 
such, this data has not been included in this thesis, although it is described now as it is 
pertinent to the discussion of this thesis. Mature cortical neuron cultures were scratch 
injured and the addition of MT was found to significantly enhance regenerative neurite 
sprouting after inury. However, pre-treatment with RAP 30 minutes prior to scratch 
injury completely blocked the MT-mediated improvement in regenerative sprouting 
(Figure 2.12, Panel A). Quantitation of regenerative neurite sprouting determined that 
MT treatment resulted in an approximately 3-fold increase in reactive axonal sprouting 
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after 24 hours and this was also abrogated by the pre-treatment with RAP (Figure 2.12B). 
Using western blotting performed on the cell lysate collected from the MT treated injured 
neuronal cultures, it was found that MT treatment led to the elevated level of 
phosphorylated MAPK (ERK1/2) within one hour of stimulation. The activation of 
ERK1/2 has also been demonstrated to induce activation of the nuclear transcription 
factor, CREB, and in subsequent experiments the level of CREB was also elevated within 
1 hour of MT treatment (Figure 2.12C).  
 
While both LRP1 and megalin knockout transgenic mice exist, these were not available 
during this PhD study. However, needlestick injury experiments using the LRP1 and 
megalin knockout mice would prove insightful in determining the precise molecular 
pathway involved. It is important to note that there are several caveats to these future 
experiments. Firstly, both LRP1 and megalin knockout mice have developmental and 
cognitive deficits, which may confound attempts to observe the regenerative response to 
brain injury in these mice. Furthermore, LRP1 and megalin are not exclusively expressed 
by neurons, with expression also reported in microglia (M. P. Marzolo et al., 2000) and 
astrocytes (M. J. LaDu et al., 2000). Hence, conditional knockout of LRP1 and megalin 
from cortical neurons prior to brain injury in adult mice would provide an elegant future 
approach to precisely determining the involvement of LRP receptors in mediating MT 
induced regenerative sprouting.  
 
Notably, most of the injected MT accumulated in ferritin-immunolabeled cells. This 
might represent a typical phagocytic response of these inflammatory cells to a foreign 
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molecule, or it might also indicate that MT has directly interacted with microglia and 
altered their functional behaviour in the injury site. These possibilities will be 
investigated in the next chapter. 
 
Overall, this chapter has demonstrated the in vivo uptake of exogenously administered 
and that MT promotes regenerative neural sprouting via a LRP-mediated mechanism.  
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Chapter 3 Exogenous MT Modulates the Microglial / Macrophage 
Response After Cortical Brain Injury.  
3.1 Introduction 
As described in the previous chapter, only a small amount of exogenously administered 
488-MT was observed within cortical neurons after cortical needlestick injury. In 
contrast, majority of the injected 488-MT appeared to accumulate within the non-
neuronal cells within the core of the lesion site. These cells are most likely to be the 
resident microglia or infiltrating macrophages (noted that ferritin is expressed by both 
microglia and macrophages). The appearance of MT inside these cells, and their reported 
expression of both LRP1 and megalin (M. P. Marzolo et al., 2000), suggest that 
exogenous MT may act upon these inflammatory cells to alter their response to brain 
injury. In this regard, several studies have reported that exogenous MT can alter the 
response of inflammatory cells to injury. A recent study has shown that exogenous MT 
significantly reduced the expression of the neurotoxic inflammatory compound quinolinic 
acid by reactive microglia following cortical brain injury and cytokine activation of 
microglia in vitro (R. S. Chung et al., 2009). Furthermore, X. Yiu et al (2005) have 
reported that exogenous MT promotes the chemotactic migration of leukocytes, and this 
response could be specifically blocked by anti-MT antibodies (X. Yiu et al., 2005). In an 
animal model of multiple sclerosis called experimental autoimmune encephalomyelitis 
(EAE), the treatment of MT was reported to modulate the inflammatory response of 
immune cells, which led to a decrease in EAE symptoms observed (M. Penkowa and J. 
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Hidalgo, 2000). These studies demonstrated that exogenous MT is capable of modulating 
the inflammatory microglia/macrophages response to injury.  
 
The aim of this chapter was to characterise the uptake of exogenous MT by microglia 
within the injured brain, and use in vitro tissue culture models to evaluate the functional 
effect of MT upon reactive microglia.  
 
3.2 Materials and Methods 
3.2.1 MT protein labeling 
MT was fluorescently tagged using the AlexaFluor® 488 Protein Labeling Kit, as 
described in the previous chapter (Refer to section 2.2.1).  
 
3.2.2 Focal-cortical Injury in Adult Rats  
This part of the experiment followed the same protocol as stated in section 2.2.2.  
 
3.2.3 Perfusion and Processing on the Cortical Samples 
This part of the experiment followed the same protocol as stated in section 2.2.3.  
 
3.2.4 Immunohistochemistry on Frozen Cortical Sections 
This part of the experiment followed the same protocol as stated in section 2.2.4 with 
slight changes in the use of primary antibody. The sections were incubated with primary 
antibodies (Rabbit anti Iba-1 from Wako use at 1:500) overnight at 4°C. It should be 
noted that the Iba-1 primarily labeled both the reactive microglia and macrophages hence 
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this allowed a better visualization of the microglial and macrophages response after 
injury. The subsequent procedures followed what has been stated in section 2.2.4 from 
here onwards.  
 
3.2.5 Preparation of Purified Primary Microglia Cultures 
Mixed glial cultures containing astrocytes and microglia were prepared from Sprague 
Dawley postnatal day 2 rat pups and cultured as mixed glial cultures as stated previously 
(A. J. Vincent et al., 2005). In short, the pups were first euthanized on ice and beheaded, 
which the heads were then transferred to cold HBSS (Hanks balanced salt solution; 
Sigma, the dissecting media), where the skin and the skull were then removed exposing 
the cortex. Under the dissecting microscope, using forceps, the whole brain was 
dislodged from the olfactory bulb, the brains collected were then placed on culture media, 
which is DMEM (Dulbecco’s modified eagle medium; Sigma) + 10% fetal calf serum 
(Gibco) + 1% penicillin-streptomycin-amphotericin B solution (Gibco). Using fine 
forceps, the two hemispheres were first separated and the cortex were then collected with 
the meninges removed. The dissected cortex was then collected in HBSS and trypsinised 
using 0.25% trypsin (Gibco) for 10 minutes on ice. Warmed culture media were then 
added to the tissues to inactivate the trypsin. The cultures were then triturated and passed 
through gauze and the tissues collected were then centrifuged for 10 minutes at 500 x G 
using centrifuge (AllegraTM X-12R, Beckman Coulter). The supernatant was then 
removed and the pellet was resuspended in 1mL of culture media. The cells were then 
added into a 75cm2 tissue culture flask and incubated at 37°C with 5% CO2 for 1 day.  
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One day after the initial dissection, culture media were changed and the cultures were 
allowed to grow to confluence (around 2 weeks after initial plating). Immediately prior 
the shaking, culture media were first changed to serum free culture media (DMEM + 1% 
penicillin-streptomycin-amphotericin B solution). The cultures were then shaken at 
250rmp at 37°C for 30 minutes, this initial shake will dislodged the microglia present in 
the cultures. The culture media containing the microglia were then collected and 
centrifuged at 500 x G for 10 minutes. The pellet containing the microglia cultures were 
then plated at 8 x 104 cells per well on 1:25 poly-L-lysine coated coverslips (pre-coated 
overnight with 1:25 poly-L-lysine; Sigma; for co-culture experiments), 2 x 104 cells per 
well on 1:25 poly-L-lysine coated coverslips (for immunostaining with antibodies against 
LRP1 and megalin) and 8 x 104 cells per well in 12 well plates precoated with 1:25 poly-
L-lysine overnight (for conditioned media collection). The microglia cultures were 
maintained in serum free media and 10ng/mL of the M-CSF (Recombinant Mouse 
Macrophage Colony Stimulating Factor from Gibco).  
 
3.2.7 Rat Cortical Neuron Cultures 
Cortical neuron cultures were prepared as reported previously from embryonic day 17 
Sprague Dawley rats (R. S. Chung et al., 2003). Briefl, the embryos were first be-headed 
and a portion of the cortex was removed using fine forceps. The tissues were then transfer 
to cold 10mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; Sigma). The 
tissue collected were then trypsinized using 0.5% trypsin incubate at 37°C for 15 
minutes. The trypsin was then removed using 3 washes with HBSS followed by trituation 
to dissociate the tissues. The dissociated tissues were then pass through the gauze and the 
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cell numbers were then determined. The dissociated cells were then plated at a cell 
density required for the experimental setup, which will be further described in later 
sections.  
 
3.2.8 Neuron and Microglia Co-Cultures 
Microglia cultures were collected and plated onto glass coverslips (8 x 104 cells per 
coverslips) as stated previously and the cultured were allowed to expand for 2 days. The 
cultures were then treated with MT (1µg/mL) and cytokines (Tumor Necrosis Factor α, 
TNFα, 10ng/mL for each) for 24 hours. The culture media of the microglia culture were 
then replaced with the culture media (NeurobasalTM medium (Gibco), supplemented with 
0.1% (f/c) B-27 supplement (Gibco), 0.1mM (f/c) L-glutamine (Gibco), and 200U/ml 
gentamicin (Gibco)) for the cortical neurons, and the cortical neuron cultures were 
collected as stated previously, and plated on top of the microglia culture at a cell density 
of 2 x 104 cells per well. The co-cultures were then incubated for 24 hours and then fixed 
with 4% paraformaldehyde for 15 minutes at room temperature follow by three PBS 
washes (5 minutes incubation per wash at room temperature) and immunolabeled with 
antibody against SMI-312 (axonal marker) using the protocol stated in the following 
section.  
 
For each treatment, the neuritis were visualised using fluorescence microcope (Leica DM 
LB2) and images were captured using the Olympus Magnifier cooled-CCD camera (5 
images per coverslips and 4 coverslips per treatment group). The lengths of the neurites 
were measured using the ImageJ (National Institute of Health) software and the data were 
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analysed statistically using ANOVA and Bonferroni post-test, with p<0.05 considered as 
significant. 
 
3.2.9 Immunohistochemistry on Cultured Cells 
After fixation, the cultures were washed with PBS three times (5 minutes incubation at 
room temperature for each wash). The cultures were then incubated overnight at 4 °C 
with primary antibodies (Mouse anti SMI312 from Covance, used at 1:1000; Rabbit anti 
Iba-1 from Wako, used at 1:500; Rabbit anti LRP1 from Sigma-Aldrich, used at 1:1000; 
Rabbit anti Megalin from Santa Cruz Biotechnology, used at 1:1000) diluted in immuno 
diluent (PBS + 0.03% Triton-X). Following incubation, the cultures were washed three 
times with PBS follow by 1 hour incubation in secondary antibodies (Alexa-Fluor 594 
anti rabbit from Invitrogen, used at 1:1000; Alexa-Fluor 594 anti mouse from Invitrogen, 
used at 1:1000; Alexa-Fluor 488 anti mouse from Invitrogen, used at 1:1000) at room 
temperature. The excess secondary antibodies were removed with three PBS washes and 
the nuclei were labeled using Nuclear Yellow (1µg/mL) for 5 minutes at room 
temperature. The Nuclear Yellow was then removed by 5 minutes incubation with PBS, 
the cultures were then mounted on glass slides using the fluorescence mounting agent 
(Dako) and dried in the dark. The cultures were then visualised on the fluorescence 
microscope (Leica DM-LB2) and images were taken using Olympus Magnifier cooled-
CCD camera.  
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3.2.10 Collection of the Condition Microglia Media and Neuron Outgrowth Experiments  
Microglia were cultured in 12 well culture dishes, coated with 1:25 poly-L-lysine and 
cells were plated at 1.6 x 105 cells per well. The microglia were maintained for 2 days in 
serum free culture media with 10ng/mL of MCSF. Half of the culture media were 
removed from each well prior to the addition of treatments, which are as follow: control 
(culture media only), TNFα (10ng/mL), TNFα with MT (1µg/mL), TNFα with MT and 
RAP (0.5µm) pretreatment for 30 minutes prior the addition of MT. The cultures were 
then incubated with the treatment agents for 24 hours, after which the media were 
collected and stored at -4°C until used.  
 
Cortical neurons were collected and plated as stated in section 2.2.6. However, instead of 
using the neuron culture media, the microglia condition media were used with a mix at 
1:1 ratio with the neuron culture media in each well prior to the addition of the neurons. 
The cultures were then incubated for 24 hours, which were then fixed using 4% 
paraformaldehyde for 15 minutes and immunolabeled with SMI312 antibody as stated in 
the previous section (refer to section 2.2.7). The neurites of the axons were then 
visualised under the fluorescence microscope (Leica DM-LB2) where digital images (5 
images per coverslips and 4-6 coverslips per treatment) were captured using Olympus 
Magnifier cooled-CCD camera and the lengths of the axons were measured using the 
ImageJ (National Institute of Health) software. The data were analysed statistically using 
ANOVA and Bonferroni post-test, with p<0.05 considered as significant. 
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3.3 Results 
3.3.1 488-MT is Present Within Microglia/Macrophage Within the Injured Brain 
As described in the previous chapter, most 488-MT that had been administered directly 
into the injury site appeared to accumulate in non-neuronal cells within the lesion cavity. 
Immunohistochemical staining using the Iba-1 antibody (marker for 
microglia/macrophages) revealed that most 488-MT accumulated in intensely Iba-1 
labeled cells, indicative of reactive microglia/macrophages (Figure 3.2). Notably, injected 
AlexaFluor-488 was also internalized by reactive microglia/macrophages (Figure 3.1). 
However, high magnification confocal images revealed that there was a marked 
difference in the morphology of Iba-1 labeled cells that had internalized AlexaFluor-488 
or 488-MT (Figure 3.3). Those Iba-1 labeled cells that had taken up 488-MT had a 
branched morphology, with numerous short branching processes emanating out from the 
cell body. However, AlexaFluor-488 containing Iba-1 labeled cells displayed a round 
morphology, with far fewer processes (Figure 3.3).  
 
3.3.2 Exogenous MT Alters the Permissivity of Reactive Microglia or Macrophages to 
Neurite Outgrowth In Vitro 
To test the effect of exogenous MT upon microglial permissivity to neurite outgrowth, 
neuron-microglia co-cultures were prepared. Cultured microglia were activated by 
treatment with the pro-inflammatory cytokine TNFα. After 24 hours, cortical neurons 
were seeded on to the microglial cultures, and neurite outgrowth assessed after 24 hours. 
TNFα-activated microglia were less permissive to neurite outgrowth than basal, 
unactivated microglia (receiving vehicle treatment) (Figure 3.4). However, when TNFα-
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activated microglia were subsequently treated with exogenous MT for 24 hours prior to 
seeding of neurons into the culture, this resulted in complete restoration in subsequent 
neurite outgrowth (Figure 3.4). It should be noted that the result from the ANOVA shown 
a slight significant different in the neurite lengths between treatments, however, the 
Bonferroni post-test shown that there were no significant difference between each group. 
Hence more repeats would have needed to confirm this result.  
 
Despite being plated at relatively high density (8 x 104 cells/well), it was noted that there 
was generally no physical contact between microglia and neurons in the neurite 
outgrowth assay described above. This suggests that rather than providing a physical 
barrier to neurite outgrowth, that TNF-α activated microglia might secrete soluble 
inhibitory factors. To confirm this hypothesis, instead of seeding the cortical neurons 
directly into microglial cultures, the neurons were plated onto coverslips in the presence 
of conditioned media collected from microglia recieving different treatment conditions. 
The treatments were vehicle (culture media only); TNFα; MT + TNFα; MT + TNFα 
with RAP pretreatment. In accordance with the previous experiments, it was found that 
the conditioned media collected from the TNFα treated microglia significantly impaired 
neurite outgrowth in comparison to media from vehicle-treated microglia. However, 
media from TNFα activated microglia that had been treated with MT was not inhibitory 
to neurite outgrowth (Figure 3.5).  
 
Previous studies have reported that microglia express LRP receptors (M. P. Marzolo et 
al., 2000). This was confirmed in this study, with cultured microglia found to express 
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both of these LRP receptors (Refer to Figure 3.6). This suggests that MT might modulate 
microglial activity through a LRP-dependent manner. To investigate this, microglial 
cultures were pre-treated with RAP (a competitive ligand for LRP receptors). Results 
demonstrated that RAP pre-treatment completely blocked the ability of MT to alter the 
permissivity of TNF-α activated microglia to neurite outgrowth, suggesting that this 
action of exogenous MT may signal through an LRP-dependent mechanism in microglia 
(Refer to Figure 3.5).  
 
3.4 Discussion 
This Chapter has demonstrated that the majority of exogenously administered 488-MT 
and AlexaFluor-488 accumulates primarily within Iba-1-labeled microglia/macrophages 
within a cortical needlestick injury. The uptake of both 488-MT and AlexaFluor-488 
might be in accordance with the well described function of microglia to phagocytose 
foreign material (R. B. Banati, 2002). However, microglia that had internalised 488-MT 
had a very different morphological appearance in comparison to those containing 
AlexaFluor-488, suggesting that 488-MT has altered the functional phenotype of 
microglia/macrophages. Using the Iba-1 antibody, it is difficult to distinguish between 
reactive microglia and infiltrating macrophages, as this antibody labels both of these 
cells. There were no antibodies available that could distinguish between these two subsets 
of inflammatory cells. However, using both microglia-neuron co-culture model and 
medium exchange experiments, it was subsequently demonstrated that the addition of 
TNFα led to a decrease in neurite outgrowth, and that addition of MT had abrogated this 
effect. Hence, this demonstrated that MT is capable of exerting a specific effect upon 
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isolated microglia in culture. Furthermore, this action of MT was blocked by the addition 
of RAP, suggesting the involvement of LRP receptors in the modulation of microglial 
function by MT.  
The uptake of MT by microglia/macrophages after cortical injury in vivo and the change 
in morphology induced by this suggests a potential role of MT in modulating 
microglia/macrophages response to traumatic brain injury. Previous studies using rats 
with EAE have shown that intraperitoneal injection of MT during EAE led to a decrease 
in the inflammatory response by reducing the infiltration of macrophages and T 
lymphocytes (M. Penkowa and J. Hidalgo, 2000). Furthermore, MT has also been shown 
both in vivo and in vitro to reduce the production of quinolinic acid by reactive microglia. 
Quinolinic acid is a neurotoxic substance known to be produced by microglia during 
inflammatory response after injury (R. S. Chung et al., 2009). It should be noted that 
although microglia/macrophages appeared to internalise both the AlexaFluor 488 and the 
488-MT, the higher magnification images revealed a clear difference in the 
morphological appearance of the microglia/macrophages in response to these treatments. 
The observation that MT treatment alters the morphology of microglia/macrophage 
within the lesion site would be in accordance with the considerable existing literature 
describing the link between microglial morphology and function in “resting” vs “trauma” 
situations. Accordingly, the branched microglial morphology that was observed within 
the injury site of 488-MT treated animals resembled that of “resting” microglia, in 
comparison to the ameboid morphology observed followed the injection of Alexa-Fluor 
dye, which correlates with an “activated microglia” phenotype (R. B. Banati, 2002). It is 
important to note that the AlexaFluor 488 itself was internalized by microglia is possibly 
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reflective of the well-characterized phagocytic behavior (“activated”) of these cells (J. 
Brockhaus et al., 1996).  
 
The results collected from the in vivo part of this study were followed up in a series of in 
vitro experiments to allow further investigation into the potential mechanism underlying 
how MT influences the inflammatory response (reactive microglia in particular) to brain 
injury. The results collected from these in vitro studies demonstrate that MT might 
potentially modulate the permissivity of activated microglia to regenerative neurite 
sprouting. In the co-culture model, the inflammatory signaling in microglia was 
simulated using the pro-inflammatory cytokine, TNFα, a well described activator of an 
inflammatory phenotype in microglia (U. K. Hanisch and H. Kettenmann, 2007; J. Mikita 
et al., 2011). Accordingly, TNFα treatment caused microglia to become significantly less 
permissive to neurite outgrowth in comparison to vehicle treatment. However, treatment 
with MT reversed this effect, causing microglia to become significantly more permissive 
to neurite outgrowth. Notably, in this co-culture set-up, there was minimal physical 
contact between neurons and microglia, suggesting that the soluble factors presence in 
the culture might be the factors influencing the outgrowth of neurites. This was supported 
by the conditioned media experiments, where the conditioned media from TNFα-treated 
microglia impaired neurite outgrowth in comparison to both control and TNFα-MT-
treatment. Interestingly, pre-treatment with RAP (a competitive ligand of LRP receptors) 
completely abrogated the effect of MT. This result suggests that MT might potentially 
modulate the secretion of soluble inhibitory factors by reactive microglia. The usage of 
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RAP also had further demonstrated that it is possibly that MT acts through a LRP-
receptor dependent manner to exert its effect on microglia.  
 
Another interesting phenomenon observed from the in vivo studies was the alteration in 
microglia/macrophages morphology caused by MT treatment in comparison to the 
vehicle treatment. A number of studies have focused upon the relationship between 
microglial morphology and its function in the injured CNS. Hanish and Kettenmann 
(2007) have proposed that the “resting” microglia should actually be referred to as 
“alternatively activated” microglia instead, as these microglia have been shown to exert 
neuroprotective properties in contrast to “activated” microglia which have an 
inflammatory and neurotoxic action in response to CNS injury (U. K. Hanisch and H. 
Kettenmann, 2007). For example, microglia have been shown to release inflammatory 
mediators in response to phagocytosing bacteria but not myelin debris, which stimulated 
secretion of anti-inflammatory factors instead. This demonstrated that microglia are able 
to interchange between the two different functional phenotypes, based mainly upon the 
type of stimulus present in the extracellular environment (as reviewed by U. K. Hanisch 
and H. Kettenmann, 2007). Further studies have recently characterized the two functional 
phenotypes of microglia in response to injury in the CNS. The “activated” microglia have 
also been referred to as M1 cells, with a functional phenotype associated with secreting 
pro-inflammatory factors as well as being inhibitory to axonal growth. The “alternatively 
activated” microglia are referred to as M2 cells, which have been shown to promote 
axonal growth as well as being neurotogenic compare to M1 (K. A. Kigerl et al., 2009). 
The finding that MT treatment induces a striking morphological change in microglia 
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suggests that MT may alter the functional phenotype of the microglia, most likely from 
M1 to M2. Unfortunately attempts to specifically immunolabel M2 microglia with the 
RELMα antibody were not successful in this study, with no RELMα labeling observed in 
the injury site in any experimental condition (results not shown). RELMα has been 
reported to be a marker of the M2 phenotype (G. Raes et al., 2002).  
 
Notably, other studies from this laboratory have shown that MTKO mice have a lower 
M2:M1 ratio compared to that of wild type mice both before and after brain injury (M. 
W. Pankhurst, 2011). Furthermore, a previous study has also reported that conditioned 
media collected from M1 microglia contains soluble inhibitory factors which impair 
neurite extension of cultured neurons (K. A. Kigerl et al., 2009). This potentially explains 
the results collected from the condition media experiments in this Chapter, where the 
addition of TNFα led to a decrease in neurite outgrowth compared to vehicle treatment. 
While microglia are known to secrete a range of soluble factors that might impede neurite 
outgrowth, study has also implicated nitric oxide and its derivatives as a key inhibitory 
mediator (G. Münch et al., 2003).   
 
Overall, the in vitro part of this study has shown that exogenous MT can altered the 
function of activated microglia and make them more permissive to neurite outgrowth, 
which is in accordance with a number of studies showing that the neuroinflammatory 
response after injury can be modulated by MT as well as the finding from the in vivo part 
of this study. This modulation effect by MT could possibly act through altering the ratio 
of M1:M2 present after the brain injury. However, further studies are still warranted in 
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order to identify the histological changes in the microglia after MT treatment both in vivo 
and in vitro using specific M2 marker such as RELMα. Furthermore, the expression of 
M2 specific RNA (ribonucleic acid) specific transcripts such as Ym1 could also be used 
to analyse the RNA samples collected from microglia culture with or without MT 
treatment to allow the confirmation of the role of MT in modulating the M1:M2 ratio 
towards a M2 bias.  
 
 Chapter 4: Metallothionein Promotes Regenerative Axonal Sprouting in Dorsal 
Root Ganglion Neurons After Physical Axotomy. 
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Chapter 5: Conclusion 
Summary of findings 
This study has shown that exogenous MT exerts pro-regenerative effects upon both 
central and peripheral neurons after injury. In accordance with previously published 
studies, exogenous MT was found to improve neuronal sprouting after injury in a LRP-
dependent manner in cortical neurons in vivo. Notably, in addition to acting directly upon 
neurons, exogenous MT also modified the microglial response to traumatic brain injury 
in vivo. The direct administration of MT into the site of cortical brain injury caused a 
substantial change in microglial morphology, as well as an increased physical association 
between reactive microglia and regeneratively sprouting axons. This effect of exogenous 
MT was characterised through a series of in vitro experiments using neuron-microglia co-
cultures, which also confirmed the involvement of an LRP-mediated mechanism.  
The second part of this study provides the first evaluation of the potential ability of 
exogenous MT to promote nerve regeneration of injured neurons from the PNS. This 
study found that exogenous MT promote both regenerative sprouting and outgrowth in 
DRG neurons after injury in vitro.  
In summary, these studies suggested that MT can promote regenerative sprouting of both 
injured CNS and PNS neurons, and might represent a potential therapeutic molecule for 
improving nerve regeneration following injury.  
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Role of MT in CNS 
The first part of this study investigated the effect of exogenously administered MT within 
the injured CNS by characterising the distribution of MT following injection into the 
injured neocortex. It was found that some MT was internalised by neurons surrounding 
the injury site, and this is in accordance with several in vitro studies demonstrating the 
uptake of exogenous MT by cultured neurons, and that this promotes regenerative neurite 
sprouting after injury.   
 
Notably, the majority of the exogenous MT was observed in reactive microglia. 
However, due to the inherent complexities of the in vivo brain injury model, it is difficult 
to precisely determine whether this has functional effects upon the behaviour of microglia 
in the injured brain, or whether it represents the phagocytic uptake of exogenously 
administered MT. Therefore, an in vitro model was developed to specifically investigate 
the potential actions of exogenous MT have upon cultured microglia. These in vitro 
experiments established an experimental model of reactive microglia, whereby treatment 
with TNFα made cultured microglia inhibitory to neurite outgrowth. Notably, treatment 
with MT made TNFα activated microglia significantly more permissive to neurite 
outgrowth. Using a series of media-exchange experiments, it was found that the 
inhibitory action of TNFα activated microglia was through the secretion of inhibitory 
factors into the culture media. This coincided with previous publications where the 
cultured microglia, activated with either cytokines or LPS, have shown to induced neurite 
retraction as well as the production of CSPGs (major components of glial scar) (G. 
Münch et al., 2003; J. Yin et al., 2009). These results suggest that exogenous MT is 
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capable of modulating the microglial inflammatory response to cytokines, which might 
contribute towards a more permissive environment to promote and support regenerative 
axonal sprouting following brain injury.  
 
Recent studies have revealed that reactive microglia may not be present as a single 
functional phenotype that is inhibitory to nerve regeneration.  In fact, it appears that 
reactive microglia (and perivascular macrophages) may actually be present in the injured 
brain as two distinct functional populations – defined broadly as regeneration inhibitory 
(M1) and regeneration promoting (M2).  However, the precise molecular signals that 
trigger the activation of these different phenotypes remain unclear. Based upon the 
morphological and functional characteristics of MT-treated microglia identified in this 
thesis, it is possible that MT represents a candidate molecule that might promote 
microglia towards a M2 phenotype. Supporting this is in a recent study, which has 
indentified that MT-deficient mice have a lower level of M2 macrophage/microglia 
activation following cortical cryolesion (M Pankhurst, manuscript in review). Future 
studies should evaluate whether MT can induce a M2 phenotype in microglia or 
macrophages.  Two experimental approaches to do this might be to: i) use RT-PCR to 
determine the expression of M2 specific markers, such as YM-1, in MT-treated and non-
treated microglial cultures, and ii) inject MT systemically into the blood of mice and 
collect the macrophages in the blood where the presence of the YM-1 can be quantitated 
using RT-PCR.  
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In summary, these studies demonstrate the potential therapeutic value of MT as a 
molecule that can promote axonal regeneration after injury, potentially through two 
distinct mechanisms: i) via direct interaction with neurons, and ii) the indirect modulation 
of the extracellular environment by altering the reactive response of microglia to improve 
permissiveness to regenerative sprouting. Notably, both of these actions appear to be 
LRP-dependent, suggesting that this receptor family may also represent a potential target 
for therapeutic intervention to promote nerve regeneration.  This is in accordance with a 
growing literature describing the involvement of LRP receptors in promoting neurite 
outgrowth (Z. Qiu et al., 2004; C. E. Fleming et al., 2009). 
 
It is well described that the primary site of MT expression / production in the brain is 
astrocytes, and particularly reactive astrocytes in response to external stress or injury. 
Notably, it has been suggested that reactive astrocytes may also secrete MT under 
physiologically stressful situations. In an experimental context, it is plausible to consider 
that the exogenous administration of MT performed in this study might mimic the 
secretion of MT by reactive astrocytes. However, so far studies have shown that in 
physiological conditions, astrocytes would not be able to secrete as high concentration as 
what was injected (i.e. 1µg). Briefly, in this study, assume that the injected MT diffused 
in a 1mm diameter sphere, which the concentration of the MT injected presence in this 
parameter would be 0.239 µg/mm3. In comparison to what had published previously in 
homogenized brain tissue samples, the physiological concentraion of MT presence was 
estimated to be about 0.0257µg/mm3 (Y. Suzuki and M. G. Cherian, 2000). In this regard, 
it is possible that in response to injury, a physiological response of reactive astrocyte 
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might be to secrete MT, which subsequently modulates the response of microglia and 
neurons to traumatic brain injury (Refer to Figure 5.1). This model is in accordance with 
studies reporting that MTKO mice have a significant deficiency in wound healing, 
resulting in alterations in non-astrocytic cells (ie: cells that do not express MT 
endogenously, but which have been demonstrated in this thesis to be responsive to 
extracellular MT) leading to increased neuronal regeneration as well as an altered 
microglial response to traumatic brain injury.  
 
It is important to note that for many years reactive astrocytes have been considered as 
being detrimental to wound healing after CNS injury. However, recent studies utilising 
the selective ablation of reactive astrocytes has revealed unexpected and important roles 
for reactive astrocytes in promoting neuronal survival and regeneration after injury. This 
thesis contributes to this important field by presenting one feasible protective action of 
reactive astrocytes, through the production and secretion of MT in response to injury, 
which can directly and beneficially modulate the microglial and neuronal response to 
injury.  
 
The role of MT in PNS  
The DRG neurons (peripheral neurons) have been recently reported to express the 
putative MT receptor megalin (LRP2). This formed the basis of the aims of the second 
part of this study, which was to determine whether exogenous MT promotes regenerative 
sprouting of DRG neurons through LRP receptors (and especially megalin). Using 
several different experimental DRG neuron culture models, it was found that treatment 
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with MT led to a significant improvement in axonal sprouting after injury. Furthermore, 
the utilization of a specialized compartmentalised culture model allowed the 
identification of neuron compartment-specific action of MT, whereby the ability of 
exogenous MT to promote regenerative axonal sprouting of injured DRG neurons co-
incided with the highly localized expression of megalin in the soma of DRG neurons. 
MT-mediated regenerative sprouting of injured DRG neurons could be inhibited by both 
RAP- and PD98059, providing further evidence for an LRP-dependent mechanism.   
 
From a therapeutic point of view, it will be important to evaluate whether MT can 
promote regenerative sprouting of DRG axons in vivo. This might involve experiments 
utilising sciatic nerve crush/cut injury in rats or mice, followed by administration of MT 
to the site of injury to see if this improves regenerative sprouting. These types of injury 
models were not available during this thesis. 
 
It is also possible that a physiological role of MT in the PNS may be to promote 
regenerative sprouting. Indeed a report by D. Ceballos et al (2003) describes that MT-3 
knockout mice have enhanced regenerative sprouting of peripheral nerves following 
facial nerve axotomy, in accordance with the inhibitory actions of MT-3 upon nerve 
regeneration (R. S. Chung et al, 2003). To determine whether MT might contribute to 
DRG nerve regeneration after injury, a logical first series of future experiments would be 
to perform sciatic nerve crush/cut injuries in MTKO and wildtype mice, and evaluate 
whether a deficiency in MT leads to impaired regenerative sprouting.  
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Conclusion  
The main focus of this study is the difference in the regenerative capacity between CNS 
and PNS after injury. This study had demonstrated the protective effect of MT in both 
CNS and PNS. However, further study, especially the action of MT in PNS should be 
further charaterized. Including the location of megalin (MT receptors) in vivo. Another 
factor warrant further investigation could be the cellular source of MT presence in the 
PNS, as well as the endogenous level of MT presence. These were the important factors 
to consider when comparing the factors that contribute to different regenerative capacity 
between the CNS and PNS.  
Overall the findings of this study provide a clearer understanding of the molecular 
mechanisms through which exogenous MT can promote nerve regeneration in both 
peripheral and central neurons after injury.  
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Figure 5.1 
 
 
 
 
 75 
Figure 5.1. Schematic diagram demonstrating the overall action of MT in promoting 
regeneration after injury in the CNS.  
(A) In uninjured bran, both the astrocytes and microglia maintain a close relationship 
with neurons 
(B) After injury, both the astrocytes and microglia become activated and lined along the 
injury site which associate in containing the injury site 
(C) The addition of MT into injury lead to a change in microglia morphology as well as 
an increase axonal sprouting, furthermore, the regenerative sprouting also appear to 
maintain a close association with the microglia 
(D) The addition of Saline (vehicle treatment) lead to a comparatively less axonal 
sprouting compare to the MT treatment, the microglia also appear to exhibit a different 
morphology as well 
(E) MT exert both intrinsic and extrinsic effect on cortical neurons, by interacting directly 
with megalin receptors on neurons to promote neuronal sprouting. MT also shown to 
potentially modulate the microglia response to injury, hence providing a more permissive 
extracellular environment, which favor the axonal to sprout through the injury site.  
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Figure 2.1 Schematic diagram demonstrating the experimental setup of the focal cortical injury 
The injury was performed using a Hamilton syringe (represented by arrow in figure A) filled with the treatment solution at the particular 
sterotactic coordinates (5mm anterior, 4.5mm lateral from lambda). The needle was lowered by 1.5mm from the surface of the brain (marked in 
B, a schematic diagram from a coronal viewpoint). The animal was then perfused at 4 days after injury and the cortical tissue containing the 
injury site (marked by the solid line in B) was then removed. The tissues were then sectioned in the horizontal plane as marked by the dotted 
lines.  
 
Figure 2.2 Control immunohistochemical staining of brain sections 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Control immunohistochemical staining of brain sections 
To ensure that there was no non-specific fluorescent signal or autofluorescent signal 
present in the brain injury sections, several different staining controls were performed. 
This involved either immunostaining with primary antibody and no secondary 
antibody, and only secondary antibody combinations. In all conditions, there was 
minimal fluorescence observed. 
 
Figure 2.3 Injection of 488-MT leads to an overall reduction in lesion volume after focal cortical brain injury. 
 
 
 
Figure 2.3 Injection of 488-MT leads to an overall reduction in lesion volume after focal 
cortical brain injury.  
Neurofilament labeling using the SMI312 antibody was performed upon cryostat cortical 
brain sections collected 4 days after focal cortical injury with injection of either 488-MT or 
AlexaFluor 488 into the injury site. Injection of 488-MT clearly resulted in reduced lesion 
volume in comparison to injection with AlexaFluor-488 alone (central lesion area marked by 
the dotted line in A and B). Furthermore, SMI312 labeled neuritic processes in AlexaFluor-
488 treated animals was fragmented and granular, which indicate the degeneration of 
processes (indicated by arrow in A). This was in contrast to 488-MT treatment, in which 
neuritic processes were brightly labeled and had a smooth appearance (B).  
(Scale Bar = 50µm) 
 
 
 
 
 
 
Figure 2.4 Cellular distribution of AlexaFluor-488 following injection into the site of focal cortical injury in vivo. 
Figure 2.4 Cellular distribution of AlexaFluor-488 following injection into the site of 
focal cortical injury in vivo. 
Cryostat brain sections collected from the injured cortex of rats receiving injection of the 
Alexa-Fluor 488 dye (green) were immunolabeled with SMI312 antibody (red). High 
magnification confocal stack images (63X) were captured near the lesion site, which clearly 
showed that the AlexaFluor-488 was found exclusively in non-neuronal cells (SMI312 
negative) (Panel A-B). The Z-axis confocal stack collected from the position indicated by the 
dotted lines confirmed that there is no colocalization between the SMI312 staining and the 
Alexa-Fluor 488 dye (Panel C-D). (Scale Bar = 16µm) 
 
Figure 2.5 Cellular distribution of 488-MT following injection into the site of focal cortical injury in vivo. 
 
Figure 2.5 Cellular distribution of 488-MT following injection into the site of focal 
cortical injury in vivo. 
Cryostat brain sections collected from the injured cortex of rats receiving injection of 488-
MT (green) were immunolabelled with SMI312 antibody (red). The high magnification stack 
images (63X) demonstrate that some neurons and neuritic processes (labeled with SMI312) 
contained 488-MT (Panel A-B). The Z-axis confocal stack confirmed the colocalization 
between MT and some SMI312 labelled neurons (Panel C-D). (Scale Bar = 16µm) 
 
 
Figure 2.6 MT immunolabeling co-localises with the distribution of injected 488-MT, 
but not the AlexaFluor 488 in the injured brain.  
 
 
Figure 2.6 MT immunolabeling co-localises with the distribution of injected 488-MT, 
but not the AlexaFluor 488 in the injured brain.  
Immunohistochemical labeling using a MT antibody was performed upon tissue sections 
from either AlexaFluor-488 (vehicle) or the 488-MT injected animals. The MT labeling in 
the cortex receiving vehicle treatment did not co-localised with the AlexaFluor-488 (A-C). 
The majority of the AlexaFluor-488 was observed primarily in the inflammatory cells located 
in the core of the injury site (marked by dotted line in panel B). In contrast, MT 
immunolabeling appeared to co-localise with some 488-MT (marked by arrow in D-F).  
Higher magnification images of the area marked in panels D-F clearly demonstrate this co-
localisation (G-I). Notably, some of the cells located further away from the injury site are 
positively labeled with the MT antibody, however do not have 488-MT (marked by arrow in 
J-L). The morphology of these cells resembles reactive astrocytes (J-L), which are the major 
cell type that expresses MT in the brain following injury (Chung et al, 2003).  
 (A-F: Scale Bar = 20µm; G-L: Scale Bar = 40µm)  
 
Figure 2.7 Regenerative axonal sprouting and accumulation of microglia/macrophage at four days after cortical needle injury 
following vehicle treatment (saline). 
 
Figure 2.7 Regenerative axonal sprouting and accumulation of microglia/macrophage at 
four days after cortical needle injury following vehicle treatment (saline). 
Panel A displays the overall injury site (labeled with neurofilament marker, SMI312, in 
green), with numerous regenerative sprouts observed entering the lesion site. A confocal 
stack (at high magnification) captured from different Z-axis depths (Panel B-E) along the 
injury edge shows some of the regenerative sprouts possess growth cone-like structures 
(marked by the arrowhead in B&C). There was very little physical association between 
regenerative sprouts (marked by arrows at B) and ferritin immunolabelled inflammatory cells 
(red) (Scale Bar = 50µm in A and 16µm in B-E).  
 
 
 
 
 Figure 2.8 Regenerative axonal sprouting and microglia/macrophage accumulation at four days after cortical needle injury 
following MT treatment. 
 
Figure 2.8 Regenerative axonal sprouting and microglia/macrophage accumulation at 
four days after cortical needle injury following MT treatment.  
The overall lesion volume was comparably smaller in MT-treated animals than vehicle 
treatment (A). The high magnification z-stack image captured along the border of the injury 
site demonstrates that many SMI312 immunolabeled regenerative axons (in green) extend a 
considerable distance into the mass of ferritin-labeled inflammatory cells (red, marked by 
arrow in B-E) (Scale Bar = 50µm in A and 16µm in B-E).  
 Figure 2.9 Regenerative axonal sprouting and microglia/macrophage accumulation at four days after cortical needle injury 
following MT + RAP treatment. 
 
Figure 2.9 Regenerative axonal sprouting and microglia/macrophage accumulation at 
four days after cortical needle injury following MT + RAP treatment.  
In comparison to both the vehicle (Figure 2.7) and MT (Figure 2.8) treatment, the MT + RAP 
treatment resulted in a considerably larger lesion volume (A). The axons (green) bordering 
the injury site were often fragmented (marked by arrow in A). The high magnification z-stack 
image collected bordering the injury site indicates that there is comparatively less 
regenerative sprouting into the injury site (B-E) (Scale Bar = 50µm in A and 16µm in B-E).  
 
Figure 2.10  
        
Figure 2.10 Quantitation of regenerative sprouting along the border of the lesion site in 
response to cortical brain injury.  
The degree of regenerative sprouting present along the injury site was automatically traced 
using HCA-Vision software, and quantitatively determined. It was found that MT treatment 
led to a significant increase in regenerative sprouting compared to vehicle treatment (p<0.05). 
Co-treatment with RAP significantly reduced the pro-regenerative effect of MT  (p > 0.05). 
(* p < 0.05 compare to vehicle treatment; # p<0.05 compare to MT+RAP) 
 
Figure 2.11 Expression of megalin (LRP2) and LRP1 in the injured neocortex. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11 Expression of megalin (LRP2) and LRP1 in the injured neocortex. 
Brain sections were labeled with antibodies against LRP1 (red) and megalin (LRP2, red), 
together with SMI312 (green). Some megalin labeling was observed in SMI312-
immunoreactive axons (Arrows in A, B and C). Furthermore, megalin was also observed 
within inflammatory cells in the central region of the lesion site (Arrowheads in A, B and C). 
However, dual labeling with antibody against both megalin and ferritin (microglia marker) 
could not be performed as both of these antibodies were raised against rabbit. The 
distribution of LRP1 in the injured brain was quite different, appearing in a distinct punctate 
distribution that was not co-localized with SMI312 labeling (Arrowhead in E and F).  Some 
LRP1 expression was noted in inflammatory cells within the centre of the lesion site, but the 
level of immunolabeling was significantly less than that observed for LRP2 (Scale Bar = 
20µm) 
 
Figure 2.12 
 
Figure 2.12 MT promotes regenerative axonal sprouting via a LRP/MAPK-dependent 
pathway.   
A scratch injury was performed upon 14 day in vitro in cortical neuron cultures using a 
microscalpel, and regenerating axons observed sprouting into the injury site by SMI-312 
imunolabelling. In the presence of 10μg/ml MT, there were significantly more regenerating 
axons present 24 hours post-injury, and the effect of MT-IIA was blocked by pre-treatment 
with RAP (A). Using HCA-Vision, all regenerating axons were traced and the total amount 
of axonal regeneration quantitatively determined (B).  MT-IIA treatment resulted in a 3-fold 
increase in axonal regeneration, which was blocked by both RAP and PD98059 (B). 
Experiments were repeated in triplicate, and error bars represent standard error values across 
the three experiments. MT treatment led to elevated levels of the phosphorylated MAPK 
(ERK1/2) and the transcription factor CREB within 1 hour of stimulation (C).   
Scale bar = 20μm (A) 10μm (D) 
 Figure 3.1 Internalisation of AlexaFluor-488 by microglia following focal cortical brain injury.  
 
 
 
Figure 3.1. Internalisation of AlexaFluor-488 by microglia following focal cortical brain 
injury.  
Immunohistochemical staining for Iba-1 was performed following AlexaFluor-488 injection 
directly into the site of focal cortical brain injury. It was found that at 4 days post-injury most 
AlexaFluor-488 was internalised by Iba-1-labeled cells (red) within the lesion zone. High 
magnification Z-stack confocal images clearly indicate the internalisation of dye within round-
shaped Iba1-labelled cells (arrows in Panel C).  
(Scale Bar in Panel A = 50µm; Panel B = 6µm) 
 
 
 
 
Figure 3.2 Microglial/macrophage uptake of 488-MT in the injured cortex.  
 
 
 
Figure 3.2. Microglial/macrophage uptake of 488-MT in the injured cortex.  
At 4 days post-injury, it was found that most 488-MT was presenced in Iba1-labeled cells 
within the lesion site. High magnification confocal z-stack compilations captured along the 
border of the injury site clearly show the presence of 488-MT inside Iba-1-labeled cells (red) 
that have a primarily branched morphology (indicated by arrow in Panel C).  
(Scale Bar in Panel A = 50µm; Panel B = 6µm) 
 
 
 
 
Figure 3.3 
 
Figure 3.3: The morphology of microglia/macrophages within the lesion site are different 
in response to AlexaFluor 488 and 488-MT treatments. 
Iba-1 labeled cells in the injured brain had a difference morphological appearance in response 
to either the AlexaFluor-488 or 488-MT treatment. Microglia/macrophages appeared to have 
ameboid morphology in response to the AlexaFluor-488 treatment, however, the 
microglia/macrophages appeared to have a branched morphology in response to 488-MT.  
(Scale Bar = 10µm) 
 
Figure 3.4 
 
Figure 3.4: Cytokine-treated microglia inhibit neurite outgrowth, which can be blocked 
by exogenous MT 
Cortical neurons were co-cultured with microglia that had been pre-treated with TNFα. After 
24 hours, cells were fixed and neurons were immunolabeled with an SMI312 antibody. It was 
found that TNF-α treated microglia impede neurite outgrowth (A), by approximately 20% in 
comparison to vehicle-treated microglia (B). However, treatment of the TNF-α activated 
microglia with MT for 24 hours prior to seeding of neurons into the culture completely 
reversed TNF-α induced inhibition (A). Quantitative analysis confirmed these observations 
(B).  
(Scale Bar = 25um) 
 
Figure 3.5  
 
Figure 3.5 Inhibition of neurite outgrowth by cultured microglia is mediated by the 
secretion of soluble inhibitory factors  
Conditioned medium was collected from cultured microglia, into which cortical neurons were 
directly plated.  After 24 hours neurite outgrowth was measured. It was found that conditioned 
medium from TNFα treated microglia was significantly (p<0.05) inhibitory to neurite 
outgrowth. However, conditioned medium from TNFα activated microglia that had been 
treated with MT was not inhibitory to neurite outgrowth, rather led to significantly (p<0.05) 
growth when compare to vehicle. Furthermore, pre-treatment of TNF-α activated microglia 
with RAP completely blocked the ability of MT to improve the permissivity of microglia 
conditioned medium to neurite outgrowth.  
 
Figure 3.6  
 
Figure 3.6 Microglia express both LRP1 and megalin (LRP2) in vitro 
Immunohistochemical staining using antibodies against both LRP1 and megalin (LRP2) show 
a distinct staining pattern in cultured microglia. Both LRP1 and megalin staining appeared to 
be punctate and perinuclear. However, not all cells appeared to express LRP1 or megalin. 
Unfortunately, the co-labelling between the LRP receptors and the microglia marker was not 
possible as these antibodies are from the same origin (Rabbit), however, the morphology of 
the cells suggested that these were microglia. (Scale Bar = 25µm)  
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Figure 4.1 MT promotes regenerative sprouting of scratch injured DRG explants in vitro. 
Figure 4.2 MT promotes neurite outgrowth of DRG in vitro. 
Figure 4.3 MT promotes neurite outgrowth through both LRP- and MAPK-dependent 
pathway 
Figure 4.4 The expression of megalin in DRG explants in vitro. 
Figure 4.5 MT promotes more extensive regenerative response when added selectively 
to 
cell bodies of injured DRGs neurons. 
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